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ABSTRACT 
Jak3, a member of the Janus family of tyrosine kinases, is essential for signaling via the 
receptors for IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21. These Jak3-dependent cytokines 
primarily activate STAT5 and are critical for lymphoid generation and differentiation. 
Using naïve CD4+ T cells from Jak3-deficient mice and wild type CD4+ T cells treated 
with a pharmacological inhibitor of Jak3, we report that Jak3-dependent cytokine signals 
are not required for the proliferation of naïve CD4+ T cells. This is illustrated by the 
similar percentage of divided cells, comparable cell divisions, intact cell cycle 
progression and unaffected regulation of cell cycle proteins in the absence of Jak3. In 
contrast to proliferation, differentiation of naïve CD4+ T cells into Th1 effector cells 
requires Jak3-dependent cytokine signals. In the absence of Jak3, naïve CD4+ T cells 
proliferate robustly, but produce little IFN-γ after Th1 polarization in vitro.  This defect is 
not due to reduced activation of STAT1 or STAT4, nor to impaired up-regulation of the 
transcription factor T-bet.  Instead, we find that T-bet binding to the Ifng promoter is 
greatly diminished in the absence of Jak3-dependent signals, correlating with a decrease 
in Ifng promoter accessibility and histone acetylation. These data indicate that while 
Jak3-dependent signals are dispensable for naïve CD4+ T cell proliferation, Jak3 
regulates epigenetic modification and chromatin remodeling of the Ifng locus during Th1 
differentiation. 
 
  
vii
Table of Contents 
ACKNOWLEDGEMENTS iv 
ABSTRACT vi 
CHAPTER I 1 
Introduction 1 
The immune system 2 
T lymphocyte proliferation 4 
T helper cell differentiation and the extracellular regulators 8 
Signaling pathways and transcription factors in Th1 cell differentiation 15 
Signaling pathway and transcription factors for Th2 cell differentiation 24 
Epigenetic regulation of T helper cell differentiation 29 
Cis-regulatory elements in the Ifng gene 37 
Jak-STAT pathway 44 
Work presented in this thesis 55 
CHAPTER II 57 
Janus-Kinase-3-Dependent Signals are not Required for the Cell Cycle 
Progression of Naïve CD4+ T Cells 57 
Introduction 58 
Results 62 
Discussion 85 
CHAPTER III 90 
  
viii
Janus-Kinase-3-Dependent Signals Induce Chromatin Remodeling at the Ifng 
Locus during T Helper 1 Cell Differentiation 90 
Introduction 91 
Results 94 
Discussion 132 
CHAPTER IV 140 
Discussion 140 
A synopsis 141 
Proliferation versus differentiation of naïve CD4+ T cells 143 
Signal pathways for Th1 differentiation                                                                  152 
Molecular mechanisms for Th differentiation 156 
 IL-2 functions as a survival and differentiation factor for CD4+ T cells following 
initial activation 162 
The significance of this work 164 
CHAPTER V 166 
Materials and Methods 166 
Mice 167 
Jak3 inhibitor 167 
Kinase assays 167 
Cell proliferation assay 168 
 Cell isolation, culture, and in vitro T cell differentiation 169      
Analysis of cell proliferation by thymidine incorporation 170 
  
ix
Analysis of cell proliferation with carboxyfluorescein diacetate succinimidyl ester 
(CFSE) 170 
Apoptotic analysis 171 
Cell cycle analysis by flow cytometry 171 
Intracellular cytokine staining 171 
Cytokine ELISA 172 
Real-time quantitative PCR 172 
Immunoblot 173 
Chromatin immunoprecipitation 174 
Restriction enzyme accessibility assay 177 
Statistical Analysis 178 
CHAPTER VI 179 
Bibliography 179 
  
x
List of Figures 
CHAPTER I 
Figure 1.1 The scheme of the cell cycle 6 
Figure 1.2 Development of T helper cell subsets 9 
Figure 1.3 Signaling pathways in Th1 differentiation 16 
Figure 1.4 Signaling pathways in Th2 differentiation 25 
Figure 1.5 Chromatin remodeling and gene transcription 31 
Figure 1.6 Map of murine Ifng locus 40 
Figure 1.7 Jak-STAT pathway 45 
Figure 1.8 Structure of Jak and STAT 48 
CHAPTER II 
Figure 2.1 CD4+ T cell proliferation appears reduced in the absence of Jak3-
dependent cytokine signals 63 
Figure 2.2 Jak3-dependent cytokine signals affect T cell survival but not proliferation
 67 
Figure 2.3 Characterization of the Jak3 inhibitor, PS078507                                      70 
                                    
Figure 2.4 CD4+ T cell survival but not proliferation is reduced by pharmacological 
inhibition of Jak3 activity 73 
Figure 2.5 Cell cycle progression is not affect by Jak3 inhibition 76 
Figure 2.6 Cell cycle proteins are regulated normally in the absence of Jak3-
dependent cytokine signals 80 
  
xi
Figure 2.7 Jak3-dependent cytokine signals are required for T cell proliferation when 
CD28 costimulation is suboptimal 83 
CHAPTER III 
Figure 3.1 CD4+ T cells in Jak3-/- OT-II Bcl2 mice are predominantly naïve 95 
Figure 3.2 Differentiation of CD4+ T cells leads to impaired IFN-γ production in the 
absence of Jak3 99 
Figure 3.3 STAT1 phosphorylation, STAT4 phosphorylation and T-bet expression are 
not impaired in Jak3-deficient Th1 cells 102 
Figure 3.4 Characterization of the Jak3 inhibitor, PS078507 105 
Figure 3.5 Pharmacological inhibition of Jak3 during Th1 differentiation leads to 
impaired IFN-γ production 108 
Figure 3.6 Schematic of the Ifng regulatory regions 111 
Figure 3.7 In vivo binding of T-bet to the Ifng promoter is impaired in Jak3-deficient 
cells 113 
Figure 3.8 IL-12Rβ2, Hlx and Ets-1 mRNA levels in Th1 cells from Jak3+/- and 
Jak3-/- OT-II Bcl2 mice 116 
Figure 3.9 Chromatin accessibility of the Ifng promoter is reduced in Th1 cells 
differentiated in the absence of Jak3-dependent signals 120 
Figure 3.10 The Jak3-dependent signals are required at 24-72h of stimulation to 
induce histone acetylation at the Ifng locus 124 
Figure 3.11 STAT5 and IL-2 are required for optimal IFN-γ production during Th1 
differentiation 129 
  
xii
Figure 3.12 IFN-γR β2 and STAT1 phosphorylation are down-regualted in the early 
stages of Th1 differentiation 135 
CHAPTER IV 
Figure 4.1 Th17 differentiation is impaired in Jak3-deficient cells 145 
Figure 4.2 Jak3-deficient cells secrete more IL-2 147 
Figure 4.3 A model of CD4+ T cell proliferation and differentiation in the absence of 
Jak3-dependent cytokine signals 150 
Figure 4.4 Signal pathways for IFN-γ transcription during Th1 differentiation        154  
Figure 4.5 Model of the orderly chromatin changes in the Ifng and Il4 locus during 
the commitment of naïve T cells to the Th1 or Th2 lineage 158 
  
 
 
 
 
 
CHAPTER I 
Introduction 
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The immune system 
The mammalian body is susceptible to infection by a wide range of pathogens, such as 
viruses, bacteria, fungi and parasites. To effectively defend against infection, the host 
forms both innate and adaptive immune responses to remove pathogenic microorganisms. 
The innate immune mechanisms act as the front line of host defense to protect the 
individual from invading microorganisms and to develop an immediate reaction after 
pathogen exposure. If pathogens elude or overcome innate defense mechanisms, adaptive 
immunity is triggered with the generation of antigen-specific effector cells, which target 
the specific infectious agents and have the potential to develop into long-lasting memory 
cells that prevent reinfection with the same microorganisms. The crucial first step in the 
adaptive immune response is the activation of naïve antigen-specific T cells.  
 
Following development in the thymus, naïve T cells enter the bloodstream and circulate 
between blood and peripheral lymphoid tissue. When naïve T cells meet foreign peptides 
bound to self MHC molecules presented by antigen presenting cells, they become 
activated, and subsequently proliferate and differentiate into armed effector cells, 
including T helper (Th) CD4 cells and cytotoxic CD8 T cells. These effector cells play an 
essential role in cell-mediated and humoral immune responses to pathogens. Cell-
mediated immune responses involve the destruction of intracellular pathogens by 
macrophages, which are activated by Th cells, and the destruction of infected cells by 
cytotoxic T cells. Humoral responses are initiated by Th cells through activating specific 
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naïve B cells to differentiate into plasma cells, which are capable of making antibodies to 
clear infectious agents. 
 
Given the essential role of lymphocytes in immune responses, the regulation of these 
cells throughout their lifetime is necessary. Failure of regulation results in persistent 
diseases or unwanted immune responses, such as autoimmune disease, transplant 
rejection and allergy.  To minimize the occurrence of these consequences, multiple steps 
of lymphocyte regulation exist, which begin with developmental regulation and continue 
with functional regulation. These regulations are carried out by different mechanisms that 
are mediated by cell surface receptors, intracellular signaling molecules and soluble 
factors.  
 
Cytokines are one of the most important soluble factors that participate in the regulation 
of the development and function of lymphocytes to establish proper immunity responses. 
Cytokines are small proteins that are released by various cells in the body in response to 
stimulus and can affect the behavior of cells bearing receptors for them. Binding of 
cytokines to their specific receptors activates intracellular signaling pathways, which 
promote cell effector function. Cytokines can act in an autocrine manner (affecting the 
cells which release the cytokines), in a paracrine manner (affecting the adjacent cells), or 
in an endocrine manner (affecting the distant cells). The common γ chain (γc) cytokine 
family expresses the γc on the cell surface and uses Janus kinase 3 (Jak3) intracellularly. 
This family of cytokines is critical for lymphocyte development, proliferation, survival 
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and differentiation. The cytokines within this family include IL-2, IL-4, IL-7, IL-9, IL-15 
and IL-21. The overall goal of this dissertation is to further investigate the importance of 
γc cytokines and their master kinase Jak3 in T lymphocyte proliferation and 
differentiation. 
 
T lymphocyte proliferation 
Quiescent T cells stay in the G0 stage of the cell cycle. Following proper stimulation, 
quiescent T cells exit the G0 phase and enter into the cell cycle to undergo cell division. 
Cell division drives clonal expansion to generate a pool of T cells that are capable of 
recognizing a specific antigen. Also, cell division drives effector T cell differentiation at 
the single cell level, illustrated by the fact that effector cytokine expression requires cell 
cycle progression (1).  
 
The cell cycle includes G1, S, G2 and M phases (Figure 1.1). The G1 phase involves 
significant synthesis of enzymes required for S phase. The S phase is the DNA synthesis 
stage, during which the amount of DNA doubles in cells. The G2 phase is marked by the 
synthesis of microtubule proteins that are required during the process of mitosis. The M 
phase is composed of nuclear division and cytoplasmic division.  
 
The molecular events that control the cell cycle occur in an ordered and directional 
sequence (Figure 1.1). The key regulatory molecules, cyclins and cyclin-dependent 
kinases (CDK), determine the cell cycle progression. Cyclins together with CDKs form 
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holoenzymes, where cyclins are regulatory subunits and CDKs are catalytic subunits. 
Activated by cyclins, CDKs induce specific target proteins to orchestrate the entry into 
the next phase of the cell cycle. CDKs are constitutively expressed in cells, whereas 
cyclins are synthesized at various stages of the cell cycle. Cyclin D is the first cyclin 
synthesized in the early G1 phase and binds to CDK4/6 to form the cyclin D/CDK 
complex. This complex phosphorylates retinoblastoma protein (Rb), leading to the 
activation of E2F. In turn, E2F promotes the transcription of varying genes, such as 
cyclin E, cyclin A and DNA polymerase. Cyclin E is produced at the late stage of the G1 
phase and binds to the existing CDK2 to drive the transition from G1 to S phase. 
Substantial cyclin A synthesis occurs in the S phase, and cyclin A also binds to CDK2 to 
form the cyclin A/CDK2 complex to initiate entry into the G2/M phase. Cyclin B is up-
regulated during the G2/M phase, and the Cyclin B/CDK1 complex causes the 
breakdown of the nuclear envelope and the initiation of mitosis. The extracellular events 
inducing cell cycle machinery consist of signals from antigen, costimulatory and growth 
factors. These signals will be discussed in detail in chapter two. 
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Figure 1.1 The scheme of the cell cycle.  
The cell cycle includes G1, S, G2 and M phases. Progression of a cell cycle is promoted 
by a number of cyclins which, when complexed with specific CDKs, drive the cell 
forward through the cell cycle. Cyclin D, associating with CDK4 and CDK6, controls 
progression through the G1 phase of the cell cycle by phosphorylation of Rb and 
activation of E2F. Cyclin E/CDK2 complex activity is rate-limiting for the S phase entry. 
Cyclin A/CDK2 drives the transition from the S phase to the G2/M phase. Cyclin 
B/CDK1 complex initiates mitosis and its deactivation causes the exit of the cell cycle. 
p27kip1 halts the cell cycle in the G1 phase by binding to and inactivating cyclin 
D/CDK4/6 and cyclin E/CDK2 complexes. 
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Figure 1.1 
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T helper cell differentiation and the extracellular regulators 
T helper lymphocytes are responsible for orchestrating the appropriate immune responses 
to a number of pathogens. The differentiation of a T helper cell is initiated when the T 
cell receptor (TCR) encounters its cognate antigen bound to MHC molecules on a 
dendritic cell (DC). There are at least three subsets of helper T cells, which are T helper 1 
(Th1), T helper 2 (Th2) and the newly discovered T helper 17 (Th17) cells (Figure 1.2). 
Th1 cells produce IFN-γ and TNF-β and are essential for the elimination of intracellular 
pathogens such as Listeria monocytogenes and Leishmania major. Th2 cells secrete IL-4, 
IL-5, IL-6, IL-10 and IL-13, which are critical for the eradiation of extracellular 
organisms including helminthes. Th17 cells produce IL-17 and IL-22 and are important 
for host defense against Klebsiella pneumonia and Bacteroides fragilis. Excess of Th1 
cells, along with Th17 cells, mediate organ-specific autoimmunity, such as type I 
diabetes, multiple sclerosis, contact dermatitis, rheumatoid arthritis, lyme arthritis, 
psoriasis and inflammatory bowel disease. Excess of Th2 cells is implicated in allergy 
and asthma.  
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Figure 1.2 Development of T helper cell subsets.  
Naive CD4+ T cells are activated by antigen-presenting cells in the presence of co-
stimulatory molecules, and differentiate into functionally distinct T helper cell subsets 
(Th1, Th2 or Th17) under the influence of indicated specific cytokines. The fully-
differentiated T helper cell subtypes influence the immune system in part through the 
secretion of specific cytokines.  
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Figure 1.2 
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Th differentiation is a finely balanced process, which is influenced by a lot of factors, 
including the type of antigen presenting cells, the duration and strength of signals, the 
ligation of costimulatory molecules, and most importantly, the local cytokine milieu. The 
identification of subsets of DCs has suggested that distinct subsets of DCs are involved in 
Th fate determination (2, 3). For instance, in the mouse system, CD8α+ DCs 
preferentially stimulate Th1 cell differentiation by secreting IL-12, whereas CD8α- DCs 
promote Th2 cell differentiation most likely through the production of IL-6. In addition to 
the type of DCs, the antigen dose can influence Th polarization (4). Several in vitro and 
in vivo studies have demonstrated that high doses of antigen are required for Th1 cell 
generation. These studies demonstrate that strong TCR/peptide interaction and sustained 
signal transduction are necessary for proliferative responses and IFN-γ production. When 
priming with low doses of antigen, only a transient signaling is generated and results in 
Th2 cell differentiation (4). Further, costimulatory molecules are involved in Th 
development. CD28/B7 (5), ICOS/B7RP-1 (6) and CD28-dependent OX40 signals (7) are 
important for generating a Th2 cell response, and B7-H3 is critical for Th1 differentiation 
(8). 
 
Cytokines play an essential role in T helper cell differentiation. Cytokines stimulate 
helper T cell maturation through inducing one lineage-specific transcription factor while 
suppressing others to select for a specific lineage. IL-12, IL-18, IFN-γ and IL-27 
significantly influence Th1 cell polarization, whereas IL-4 and IL-2 remain the eminent 
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cytokines for Th2 cell development. IL-23, IL-6, IL-21 and TGF-β are involved in the 
differentiation of naïve CD4+ T cells into Th17 cells.  
 
IL-12 is produced mainly by activated macrophages and DCs and is a heterodimer 
composed of two subunits, p35 and p40. Naïve CD4+ T cells are unresponsive to IL-12 
due to lack of IL-12 receptor (IL-12R) β2 expression, which is required to form a 
functional IL-12R with IL-12R β1 chain. Both IL-12R β1 and IL-12R β2 are up-
regulated by activation through the TCR.  However, IL-12R β2 is expressed in Th1 
differentiating cells and extinguished in Th2 differentiating cells, which serves as a 
mechanism by which CD4 T cells are able to commit to a particular Th cell lineage. 
Binding of IL-12 to IL-12R activates the Janus family tyrosine kinase (Jak) and signal 
transducer and activator of transcription (STAT) signaling pathway, specifically the Jak2 
and Tyk2 kinases and STAT4. Mice deficient in IL-12, IL-12R β1, IL-12R β2 and 
STAT4 have profoundly reduced Th1 responses, indicating the central role of IL-12 
signaling in Th1 immunity. Although IL-12/STAT4 signaling is not needed for initial 
Th1 cell differentiation, it amplifies Th1 cell responses by augmenting the production of 
IFN-γ and promoting the expression of the IL-18 receptor (IL-18R) in differentiating Th1 
cells. IL-18 is a member of the IL-1 family of cytokines and is secreted by activated 
macrophages and DCs. It acts synergistically with IL-12 to enhance IFN-γ production (9). 
Besides being the signature cytokine of Th1 cells, IFN-γ  is a cytokine that educates naïve 
CD4+ T cells to differentiate into Th1 cells. In addition to naïve CD4+ T cells and Th1 
cells, IFN-γ is produced by nature killer (NK) cells, CD8+ T cells, macrophages and DCs. 
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IFN-γ promotes Th1 cell differentiation through binding to its receptor, which is 
composed of IFN-γ receptor (IFN-γR) 1 and IFN-γR2. The IFN-γR is present on many 
cell types and utilizes Jak1 and Jak2 kinases and the transcription factor STAT1. IFN-γ 
activates and reinforces the production of IL-12 by macrophages and DCs to indirectly 
induce Th1 cell polarization. In addition, IFN-γ can directly induce T cells to differentiate 
into Th1 cells by promoting the expression of the Th1 cell master transcription factor, T-
bet. Mice deficient in IFN-γ, IFN-γR or STAT1 have impaired immune responses to L. 
major, which is controlled via the development of a Th1 cell response. IL-27 is also 
important in Th1 cell differentiation. IL-27 is a novel cytokine that is structurally related 
to the IL-12 family and is mainly produced by activated macrophages. It signals through 
the IL-27 receptor (IL-27R), which is expressed in naïve CD4+ T cells and NK cells. 
Although IL-27 is thought to promote inflammation by inducing Th1 cell differentiation 
(10, 11), recent studies demonstrate that IL-27, together with IL-6 and TGF-β, promotes 
IL-10 production by activated CD4+ T cells to suppress pro-inflammatory immune 
responses (12-15).  
 
IL-4 is critical for Th2 cell differentiation and potentially initiates the development of 
these cells. IL-4 is secreted by many cell types, such as Th2 cells, naïve CD4+ T cells, 
mast cells, basophils, eosinophils and natural killer T (NKT) cells. IL-4 functions through 
the IL-4 receptor (IL-4R), which is expressed on naïve CD4+ T cells and consists of the 
common γ chain (γc) subunit and the IL-4Rα chain. After binding of IL-4 to IL-4R, Jak1 
and Jak3 kinases are recruited to the receptor complex to activate STAT6. This signaling 
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event mediates the induction of the master transcription factor for Th2 cells, GATA3. In 
addition, IL-2 has been implicated in Th2 cell differentiation (16). IL-2 signals through 
the IL-2 receptor (IL-2R), which is composed of IL-2Rα, IL-2Rβ and the γc chain. IL-
2Rβ and the γc chain are expressed on the surface of naïve CD4+ T cells, whereas the 
expression of IL-2Rα is induced after TCR engagement. Jak1 and Jak3 are downstream 
of the IL-2R complex and promote STAT5 activation. The effect of IL-2 on Th2 cell 
differentiation is through the activation of STAT5, which will be discussed in the later 
section. 
 
It has previously been thought that IL-23 is involved in Th1 cell differentiation (17). 
However, recent studies showed that IL-23 is closely associated with a novel subset of 
pro-inflammatory CD4+ T cells that produce IL-17 (18). IL-23 is another member of the 
IL-12 family and is a heterodimer composed of the p40 subunit of IL-12 and a novel 
subunit, p19. The receptor for IL-23 has two subunits. One subunit shares the IL-12Rβ1 
with IL-12 and the second subunit is IL-23R. The Jak/STAT pathway utilized in IL-23 
signaling includes Jak2, Tyk2, STAT1 and STAT3. Naïve CD4+ T cells do not express 
the IL-23R, therefore, IL-23 appears to not be responsible for the initial induction or 
commitment of Th17 cell. Rather, IL-23 is essential for the maintenance or expansion of 
Th17 cells. In vitro data show that the differentiation of Th17 cells is induced by the 
combination of IL-6 and TGF-β (19). IL-6 acts on naïve T cells to promote the 
expression of IL-21, which promotes continued expression of IL-21 through an autocrine 
pathway (20, 21). In addition to the inhibition of IFN-γ and IL-4-dependent pathways, 
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TGF-β synergizes with IL-21 to induce the expression of retinoic acid receptor-related 
orphan receptor γ-t (RORγt), a master transcription factor for Th17 cells, via a STAT3-
dependent mechanism (21, 22).  
 
Signaling pathways and transcription factors in Th1 cell differentiation 
CD4 helper T cells are classified by their distinct patterns of cytokine gene expression, 
which is controlled at the level of transcription. Understanding the signaling pathways 
and transcriptional mechanisms that determine the expression of IFN-γ and IL-4 has led 
to insights into the regulation of lineage commitment of T helper cells. Over the past 
twenty years, tremendous progress has been made in identifying the signaling pathways 
and transcription factors that control Th1 (Figure 1.3) and Th2 cells. 
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Figure 1.3 Signaling pathways in Th1 differentiation.  
Signals from TCR ligation trigger the release of Ca2+ from the ER, which promotes the 
entry of extracellular Ca2+ into cells. Calcium-bound calmodulin activates the 
phosphatase calcineurin (Cal), which dephosphorylates NFAT. Dephosphorylated NFAT 
goes into nucleus and non-selectively stimulates both IFN-γ and IL-4 production. After 
IFN-γ binds to the IFN-γ receptor (IFN-γR), Jak1 and Jak2 are activated which 
phosphorylate STAT1. Phosphorylated STAT1 translocates into nucleus to promote the 
expression of the most important Th1 transcription factor, T-bet. T-bet, in turn, increases 
IFN-γ and IL-12Rβ2 expression, inhibits IL-4 expression, and maintains Th1-cell-lineage 
commitment. In the mean time, IL-12R signaling activates STAT4 through Jak2 and 
Tyk2, which further enhances the production of IFN-γ.  
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Figure 1.3 
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T-bet 
An important advance in searching for transcription factors that underlie the cellular 
program of Th1 cell differentiation was the discovery of T-bet (T-box expressed in T 
cells). T-bet, also known as Tbx21, belongs to the T-box family of transcription factors, 
which have homology within a 200-amino acid DNA-binding domain called the T-box. 
T-bet is expressed exclusively in the lymphoid tissues, especially in the spleen, thymus, 
lymph node and lung. T-bet is detected in a variety of cells that produce IFN-γ, including 
CD4+ T cells, CD8+ T cells and NK cells. In CD4+ T cells, T-bet is rapidly and 
specifically induced in developing Th1 but not Th2 cells, and T-bet expression correlates 
with induction of IFN-γ.  
 
It was originally thought that T-bet might be regulated by the IL-12/STAT4 pathway to 
mediate Th1 cell differentiation. However, this theory was challenged by Reiner and 
colleagues via the demonstration that T-bet mRNA is normal in STAT4-deficient T cells 
under Th1-polarizing conditions. Further, this group show that T-bet acts prior to the IL-
12-dependent effect on Th1 cell differentiation (23). In addition, T-bet expression has 
been shown to be controlled by the IFN-γ/STAT1 signaling pathway but not by the IL-
12/STAT4 pathway (24, 25). Overexpression of T-bet in Th2 cells leads to the 
endogenous T-bet expression, which suggests that induction of T-bet occurs in an 
autocrine mechanism (26). However, evidence is lacking for a STAT1-independent 
mechanism of T-bet autoactivtion, and thus, STAT1 is indispensable for T-bet expression 
(25).  
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Gain-of-function and loss-of-function in T-bet demonstrate that T-bet plays a central role 
in Th1 cell differentiation. For example, retrovial transduction of T-bet into naïve CD4+ 
T cells results in endogenous IFN-γ production (27). Overexpression of T-bet in 
developing or fully differentiated Th2 cells leads to a dramatic increase in IFN-γ 
production and a decrease in IL-4 secretion, indicating the powerful function of T-bet in 
redirecting Th2 cells at various stages into Th1 subset (27). The essential role of T-bet in 
regulating Th1 cells is confirmed by analysis of mice lacking T-bet. T-bet-deficient mice 
have no abnormality in thymocyte development or peripheral lymphoid organ homing 
(28). In vitro, isolated T-bet-deficient CD4+ T cells have a severe defect in IFN-γ 
production in response to Th1-inducing conditions. Further, mice lacking T-bet fail to 
establish a Th1 cell response to L.major infection in vivo. Moreover, T-bet-deficient mice 
develop a spontaneous reactive airway disease similar to human asthma (29). Taken 
together, T-bet is essential in initiating Th1 cell development from naïve CD4+ T cells. 
 
The mechanisms of T-bet on Th1 cell differentiation are not clear. Some studies suggest 
that the function of T-bet in promoting Th1 cell development may be indirect. For 
instance, overexpression of T-bet promotes the expression of IL-12R β2 chain, leading to 
the responsiveness of CD4+ T cells to IL-12 and subsequently enhancing Th1 cell 
polarization (25). Further, in T-bet-deficient mice, the failure to generate a Th1 cell 
response is always accompanied by an increase of a Th2 cell response, suggesting the 
critical role of T-bet in Th1 cell differentiation may partially be through repressing the 
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Th2 cell program. On the other hand, some evidence showed that T-bet directly regulates 
IFN-γ production. Several putative T-box binding sites were identified in the Ifng gene 
locus (30). T-bet either is capable of potently transactivating the Ifng gene (27, 31) or 
plays a role in chromatin remodeling of the Ifng gene, which will be discussed in detail 
later.  
 
STAT4 
STAT4 was cloned by Darnell and colleagues (32) and later found to be associated with 
IL-12 signaling (33). Jak2 and Tyk2 are the kinases activated by IL-12 signaling to 
phosphorylate STAT4. The phenotype of STAT4-deficient mice demonstrates the 
important role of STAT4 in Th1 cell differentiation. STAT4 knockout mice have defects 
in cell proliferation and IFN-γ production in response to IL-12 signaling (34, 35), and the 
expression of IL-18R is also impaired. Although the activation of STAT4 is correlated 
with the capacity of IFN-γ production, IFN-γ is not totally abrogated in the absence of 
STAT4, suggesting a STAT4-independent mechanism of IFN-γ production (36, 37). 
More studies show that STAT4 is not required for the initiation of IFN-γ production (23), 
but this transcription factor is essential to augment IFN-γ production and to maintain Th1 
cells.  
 
The manner in which STAT4 mediates Th1 development remains to be determined, but 
evidence suggests that it may transactivate IFN-γ production. Hoey and colleagues found 
that STAT4 binds to the nonconsensus low-affinity STAT sites within both the promoter 
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and first intron of the Ifng gene to stimulate Ifng transcription (38). The critical role of 
STAT4 activation in the interferon-gamma response during viral infection may be 
through direct binding to the Ifng gene (39). The synergistic function of IL-12 and IL-18 
to enhance Ifng mRNA expression is dependent on activation of STAT4 since activated 
STAT4 up-regulates the binding activity of AP-1, an IL-18-induced activator protein (40). 
Other evidence indicates that STAT4 contributes to the chromatin remodeling activity of 
the Ifng gene, which will be discussed later. 
 
STAT1 
STAT1 is another signal transducer and activator of transcription involved in Th1 cell 
polarization. Jak1 and Jak3 activate STAT1 to carry out its biological functions. 
Significant progress towards understanding the function of STAT1 in cellular physiology 
resulted from analysis of mice lacking STAT1 expression (41). These mice display no 
gross developmental defect, however, they are extremely susceptible to viral infection, 
mainly due to the IFN resistance (41). Although the role of STAT1 in Th1 cell 
differentiation may be mediated by direct binding to the Ifng promoter (42), both in vitro 
and in vivo studies favor that STAT1 is associated with the induction of T-bet in Th1 cell 
differentiation. It has been reported that T-bet expression is dependent on IFN-γR 
signaling with subsequent STAT1 phosphorylation (25). In vivo studies show a positive 
feedback loop of Ifng gene regulation by which IFN-γ/STAT1-driven T-bet expression 
induces further IFN-γ production in Th1 cells (24). In addition to being the principal 
target of the IFN-γR signaling, STAT1 is activated by IL-27 signaling to induce T-bet 
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expression (10, 43). Both IFN-γR and IL-27R are expressed in naïve CD4+ T cells, 
suggesting that STAT1 plays an important role during the initial stages of Th1 cell 
differentiation by inducing the expression of T-bet and the subsequent IL-12Rβ2 
expression.  
 
Hlx 
Hlx (H2.0-like homeobox 1) is expressed in multiple hematopoietic lineages, including 
CD4+ T cells, CD8+ T cells, NK cells and B cells (44, 45). Reiner and colleagues (26) 
found that Hlx is more highly expressed in Th1 cells than Th2 cells. It appears after 3 
days of Th1 cell differentiation and is induced more slowly than T-bet in differentiating 
Th1 cells. Retroviral overexpression of T-bet into Th2 cells induces the expression of Hlx 
and introduction of a dominant-negative T-bet into developing Th1 cells antagonizes the 
activation of Hlx transcription. Thus, Hlx appears to be a target gene of T-bet.  
 
The function of Hlx in Th1 cell differentiation was addressed by using the gain-of-
function approach, since deletion of Hlx results in lethality at embryonic day 15 due to 
severe hypoplasia of the liver and gut. Although ectopic expression of Hlx alone does not 
substantially increase IFN-γ secretion, introduction of both Hlx and T-bet results in a 
dramatic increase of IFN-γ expression, both in the frequency and the amount of IFN-γ 
produced per cell. This result indicates a synergistic action between Hlx and T-bet in Th1 
cells (26). Similarly, the Hlx transgenic cells display an increased number of IFN-γ 
producing cells in response to keyhole limpet hemocyanin (KLH) immunization or to 
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culturing under Th2-skewing conditions (46, 47). Further, the dominant-negative Hlx 
leads to a significant impairment in IFN-γ synthesis (47). Although the molecular basis 
for the function of Hlx is not clear, the physically interaction between Hlx and T-bet may 
mediate their cooperative effects on Ifng transcription (47). 
 
Ets family members 
Ets family of transcription factors are characterized by an evolutionarily-conserved ETS 
DNA binding domain which contains a core purine-rich GGAA/T motif. In general, these 
transcription factors interact with a multitude of co-factors to elicit gene-specific 
responses and drive distinct biological processes (48), (49). 
 
ERM, an Ets family transcription factor, is the first Th1-specific transcription factor 
selectively induced by IL-12 signaling through STAT4 (50) ERM regulates Ifng 
transcription via a cooperative interaction with STAT4, and over-expression of ERM by 
retrovirus into STAT4-deficient cells does not restore normal IFN-γ production (50). 
 
Ets-1 (E26 transformation-specific-1) is another member of the Ets family of 
transcription factors. Deficiency of Ets-1 severely impairs the differentiation and function 
of Th1 cells (51). Ets-1 knockout cells secrete much less IFN-γ under Th1-polarizing 
conditions and are unable to induce colitis in SCID mice, an animal model of Th1 cell-
mediated disease. There are multiple mechanisms by which Ets-1 promotes the 
development of Th1 cells. First, T-bet expression is markedly reduced in Ets-1-deficient 
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Th1 cells suggesting that Ets-1 is involved in induction of T-bet. Second, Ets-1 serves as 
a cofactor of T-bet by binding to the proximal region of the Ifng promoter to enhance the 
activity of T-bet. Third, Ets-1 is required for the activation of STAT4 during Th1 cell 
differentiation (51).  
 
Signaling pathway and transcription factors for Th2 cell differentiation 
Similar to Th1 cell differentiation, there are several transcription factors essential for Th2 
cell polarization (Figure 1.4), such as GATA-3 and c-Maf. Non-Th2 cell specific factors, 
such as STAT6, nuclear factor of activated T cells (NFAT) and STAT5 also contribute to 
regulate IL-4 production. Here, I focus on GATA3, STAT6 and STAT5. 
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Figure 1.4 Signaling pathways in Th2 differentiation.  
TCR signaling induces the activation of NFAT, a Th2 non-specific transcription factor, 
leading to rapid acute transcription of Il4 gene. IL-4 receptor ligation through binding of 
IL-4 to IL-4R phosphorylates STAT6 via Jak1 and Jak3, resulting in the up-regulation of 
GATA3 expression. GATA3 expression also undergoes positive feedback by 
transcriptional autoactivation. The GATA3 protein in turn increases IL-4 expression, the 
hallmark cytokine for Th2 cells. Ligation of the IL-2R activates the associated Jak1 and 
Jak3 kinases, resulting in tyrosine phosphorylation of STAT5, which stabilizes the 
accessibility of the Il4 gene. 
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Figure 1.4 
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STAT6 
The transcription factor STAT6 is activated by Jak1 and Jak3 upon the binding of IL-4 to 
the IL-4R and plays a central role in modulating Th2 cell differentiation. STAT6 
knockout mice have impaired Th2 cell differentiation and increased susceptibility to 
helminthic infections, a disease prevented by Th2 immunity (52). Ectopic expression of 
an inducible, activated STAT6 into developing Th1 cells significantly increases IL-4 
expression (53). STAT6 function is mainly mediated by up-regulation of the Th2 cell 
specific transcription factor GATA3 (53), (54) or by direct binding to the Il4 locus (55).  
 
While STAT6 is important for maximal Th2 cell development, STAT6-deficient cells are 
capable of producing Th2 cell cytokines and developing in vivo Th2 cell responses to S. 
mansoni infection. These results suggest a STAT6-independent mechanism of 
differentiation of Th2 cells (56). In studies with a Th2-eliciting parasitic infection, the 
primary IL-4 response remains intact in STAT6-deficient mice, while secondary and 
memory responses are abrogated (57). These data indicate that the function of STAT6 is 
to stabilize rather than initiate Th2 cell development. 
 
GATA-3 
The zinc finger protein GATA-3 was originally cloned as a T-cell-specific transcription 
factor that binds to the enhancer of the TCRα gene (58). Although GATA-3 is very 
important for thymocyte development (59, 60), two groups found that the expression of 
GATA-3 is strongly increased during Th2 cell differentiation and decreased during Th1 
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cell differentiation (61, 62). GATA-3 expression is robustly up-regulated by IL-4 
signaling via STAT6 (53). However, the IL-4/STAT6 pathway does not appear to be 
indispensible for GATA-3 induction. GATA-3 can be induced through a STAT6-
independent autoactivaton pathway (63).  
 
Introduction of GATA-3 using retroviral vectors or GATA-3 transgenic mice enhances 
the expression of all Th2 cell cytokines, even when CD4+ T cells are cultured under Th1-
skewing conditions, and a dominant-negative GATA-3 inhibits Th2 cell differentiation 
(61, 62). These studies suggest an essential role for GATA-3 in Th2 cell development. 
 
The mechanisms by which GATA-3 induces Th2 cell cytokine expression depend on 
distinct cytokines. For instance, GATA-3 directly binds to the critical elements in the Il5 
or Il13 promoters to induce transcription of these genes (62), (64, 65). However, the 
binding of GATA-3 to the promoter region of  the Il4 gene only weakly induces Il4 
transcription (66),(67). Instead, GATA-3 acts through a number of regulatory elements to 
control Il4 gene expression (68). In addition to being a cis-acting transcriptional regulator, 
GATA-3 influences chromatin remodeling of IL-4 to affect Il4 gene transcription (69).   
 
STAT5 
Following the binding of IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21 to their individual 
receptors, the transcription factor STAT5 is activated by Jak1 and Jak3. IL-2 has long 
been implicated in Th2 cell differentiation and IL-4 production (16). Recent reports 
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substantially clarify the role of the IL-2/STAT5 pathway in Th2 cell differentiation. In 
STAT5a-deficient mice, Th2 cell differentiation and CD4+ T cell mediated allergic 
inflammation is significantly diminished (70). The intrinsic expression of STAT5a 
appears to be required for Th2 cell differentiation (71), and Stat5a promotes Th2 cell 
differentiation in a Stat6-independent manner (72). Further, it has been reported that the 
role of IL-2 on Th2 cell differentiation does not depend on the cell growth or survival 
effect of IL-2, rather, IL-2 signals transmit through STAT5 to stabilize the accessibility 
of the Il4 gene (73). Overexpression of a constitutively active mutant form of STAT5a 
(STAT5A1*6) generates Th2 cell differentiation in the absence of IL-4 or in STAT6- or 
IL-4Rα-deficient cells (74). Although STAT5A1*6 does not enhance GATA-3 
expression, GATA-3 synergistically acts with STAT5A1*6 to cause optimal Th2 cell 
priming since GATA-3 and STAT5A1*6 parallelly render the Il4 gene accessibility (74).  
 
Epigenetic regulation of T helper cell differentiation 
“Epigenetic regulation” refers to the modification of nucleosomal histones and cytosine 
residues in DNA without changing the intrinsic nucleotide sequence information encoded 
in the DNA. Epigenetic codes are potentially heritable, to provide a means for 
propagating information from parental cells to their daughter cells. 
 
Overview of epigenetic regulation of gene expression 
Gene transcription in eukaryotic cells occurs in the context of chromatin, where DNA 
winds around a group of eight histone proteins to form a structure called a nucleosome. 
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Negatively charged DNA binds to positively charged histones. Condensed chromatin 
generally represses gene transcription, whereas opened chromatin promotes gene 
expression.  
 
In addition to differential expression of transcription factors in a cell, gene transcription is 
controlled by the accessibility of a gene to transcription factors. This process is mediated 
by binding of chromatin remodeling factors to the specific DNA element within the 
context of nucleosome DNA to recruit other chromatin remodeling factors, which results 
in the disruption of local chromatin structure and an increase in the accessibility of a gene 
to transcription machinery. Following chromatin remodeling, transcription factors and 
RNA polymerase II containing complexes are able to access the promoter sequences 
surrounding the coding region of a gene to start gene transcription (Figure 1.5). Thus, by 
modulating the accessibility of a gene to the transcription factors, epigenetic factors may 
facilitate or silence gene transcription. 
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Figure 1.5 Chromatin remodeling and gene transcription.  
The condensed chromatin is generally associated with gene repression. Alteration of 
chromatin structure from the compact chromatin to the open chromatin is brought about 
by a process called chromatin remodeling, which is the first level of transcription 
regulation. DNA remodeling factors recruit histone acetyl transferase, which acetylates 
histones and opens the chromatin. Transcription factors and RNA polymerase then access 
the open loci and bind to their responsive elements to promote gene transcription. 
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Figure 1.5 
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The major mechanisms of epigenetic regulation in mammals include DNA methylation 
and post-translational modifications of histones. Cytosine methylation in CpG 
dinucleotides of DNA is strongly correlated with gene silencing (75). The amino-terminal 
tails of histones, as well as some internal sites, are subject to several covalent 
modifications, including acetylation, methylation, phosphorylation and ubiquitination. 
Individual histone modification can permit or repress the accessibility and transcription 
activity of a gene. For example, histone H3 acetylation of lysine 9 and 14 are positively 
associated with transcription activity; lysine 4 di- and trimethylation of histone H3 is 
broadly distributed throughout transcriptionally active genes.  In contrast, histone H3 
lysine 27 trimethylaiton and lysine 9 di- and trimethylatoin are correlated with gene 
silencing.  
 
Histone acetylation has been well studied. It is proposed that hypoacetylation of histone 
proteins is associated with inaccessible or repressive chromatin, whereas hyperacetylation 
of histones is typically associated with open or active chromatin (76). The acetylation of 
histones is regulated by opposing actions of histone acetyltransferases (HATs) and 
histone deacetylases (HDACs). Histone hyperacetylation increases the accessibility of a 
gene to transcription factors via an alloseteric change in nucleosome structure, which is 
caused by neutralizing the charge attraction between histones and DNA (77). Some 
transcription factors have intrinsic HAT activity (78) and others recruit proteins which 
are HATs. Histone deacetylases remove the charge-neutralizing acetyl group to 
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deacetylate histones and silence gene expression. HDACs are usually recruited to DNA 
by specific transcriptional regulatory factors. 
 
Epigenetic regulation of Th cell differentiation 
The importance of epigenetic regulation in the development and proper function of the 
immune system is receiving more attention. Specifically, cell fate determination gives the 
most striking example of how epigenetic mechanisms regulate gene expression. When 
naïve CD4+ T cells differentiate into Th1 or Th2 cells, cytokine loci undergo changes in 
chromatin structure. One set of genes is epigenetically activated, and the other is silenced. 
These alternations in chromatin structures can be heritably maintained.   
 
IL-2 (79) and IFN-γ (80) are the first two cytokine genes whose expression are enhanced 
by the prevention of DNA methylation by 5-azacytidine treatment. These studies first 
established a correlation between changes in chromatin structure and cytokine 
transcription. In 1998, Rao and colleagues (81) demonstrated that T helper cell 
differentiation leads to long-range alterations in chromatin structure of differential 
cytokine genes, which gave the first definitive evidence of chromatin remodeling at 
cytokine gene loci being functionally associated with productive T cell differentiation. 
Reiner and colleagues (1) found that presence of inhibitors of histone deacetylase or 
cytosine methylation during T helper cell differentiation profoundly represses effector 
cytokine expression, confirming the importance of epigenetic events in T cell fate 
determination.  
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DNA methylation, histone methylation and histone acetylation have been shown to play 
important roles in Th1/Th2 differentiation. Among these, extensive studies using 
chromatin immunoprecipitation (ChIP) demonstrated that Th1/Th2 differentiation is 
highly associated with changes in histone acetylation at different cytokine loci (55) (82-
85). It has been shown that naïve CD4+ T cells have almost no detectable histone 
acetylation on the Ifng and Il4 loci. TCR signals initiate chromatin remodeling and locus 
opening in a cytokine-independent fashion. Subsequently, polarizing cytokine signals 
maintain and reinforce the accessible state at the relevant cytokine locus elicited by the 
TCR (55), (82). The polarized acetylation pattern of cytokine loci is maintained through 
more than 20 cell divisions, even in the absence of polarizing cytokine signals or TCR 
signals, and enhanced in response to restimulation (83). However, the polarized cytokine 
gene acetylation pattern in Th1/Th2 cells still has the capability to change if the polarized 
cells are cultured under opposite cytokine conditions (83). For example, after Th1 or Th2 
clones are recloned with opposite polarizing conditions,  the recloned cells display 
increased histone acetylaton at the formerly hypoacetylated cytokine loci with no 
reduction of histone acetylation at the originally hyperacetylated cytokine loci. These 
data indicate that hypoacetylation per se is not necessary to maintain irreversible gene 
silencing (83).  
 
Transcription factors involved in epigenetic regulation of Th differentiation 
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During Th1 and Th2 cell differentiation, non-selective histone hyperacetylation is found 
at both the Ifng and Il4 loci (55), (82). These early changes require TCR signaling but not 
polarizing cytokine signals. Therefore, Th1 and Th2 differentiation share a common 
initiation pathway emanated from TCR. TCR ligation leads to the release of intracellular 
calcium stores, stimulating the calcium-dependent phosphatase calcineurin that 
dephosphorylates NFAT. NFAT is a lineage non-specific transcription factor for Th1 and 
Th2 cell differentiation, which goes into the nucleus and non-selectively stimulates both 
IFN-γ and IL-4 production (86). 
 
Lineage specific transcription factors are also involved in epigenetic regulation of Th 
differentiation, although the precise mechanisms through which these transcription 
factors mediate changes in chromatin are not clear. STAT proteins have been shown to be 
critical for chromatin remodeling of cytokine loci. In STAT4 deficient T cells, DNase 
hypersensitivity (23) and histone acetylation (82), (85) at the Ifng locus are significantly 
lower under Th1-skewing conditions. In the absence of STAT6, neither histone 
hyperacetylation (55) nor DNA demethylation (87) around the Il4 locus can be fully 
established. STAT4 binds directly to the Ifng gene (38) and STAT6 to the Il4 gene (55). 
How STAT4 and STAT6 mediate their functions remains unknown. Possible 
mechanisms include recruiting chromatin remodeling factors, acting as a cofactor of other 
transcription factors, or inducing the expression of master transcription factors, such as T-
bet or GATA-3. The role of T-bet and GATA-3 in epigenetic changes has been actively 
studied. Overexpression of these factors results in substantial changes in chromatin 
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structure at the cytokine gene loci. Ectopic expression of T-bet induces DNase 
hypersensitivity of the Ifng gene and enhances Ifng gene transcription, even in the 
absence of STAT4 (23, 82). Likewise, overexpression of GATA-3 leads to alterations 
within the Il4 gene, including the appearance of DNase hypersensitivity sites (69), 
histone acetylation(88) and DNA demethylation (1). Loss-of-function studies further 
confirmed the importance of these factors in epigenetic regulation. In T-bet knockout T 
cells, hyperacetylation of the Ifng promoter is impaired (55). In conditional GATA-3-
deficient T cells, there is an increase in DNA methylation at the Il4 locus and a decrease 
in histone hyperacetylation at the Il5 locus (89). The order in which these transcription 
factors act and if this interaction is direct or not has not been elucidated.  
 
Cis-regulatory elements in the Ifng gene 
The Ifng gene is located on mouse chromosome 10 and human chromosome 12. IFN-γ 
expression is controlled at the transcription level. Regulation of transcription is a 
complex process that involves the binding of transcription factors to cis-regulatory 
elements that include the promoter and the more distal regulatory elements, such as 
enhancers, insulators and silencers. The proximal promoter is an important cis-regulatory 
module which specifies the site of transcription initiation. The distal regulatory elements 
are commonly located within around 50 kb upstream or downstream of the transcription 
initiation site of a gene, but they can be located up to several hundred kilobases away. In 
general, there are three methods to search for regulatory elements. The first method 
involves using bioinformatic approaches to find the conserved non-coding sequences 
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(CNS) between different species, since the important regulatory elements are usually 
conserved evolutionarily. The second method includes the utilization of a DNase I 
hypersensitivity assay to identify the relative open chromatin structures. These open 
chromatin structures are susceptible to digestion by DNase I and regulatory elements are 
commonly found in open chromatin to allow access of transcription factors to specific 
DNA sequences to control gene expression. The third method is to perform functional 
analysis, such as a promoter-reporter assay or the use of transgenic and knockout mice. 
Although bioinformatic approaches are useful for the initial identification of regulatory 
elements, a combination of bioinformatic and experimental analysis is required to 
establish whether a given CNS is actually utilized by a particular cell type.  
 
While the Th2 cytokine locus has been substantially studied and has emerged as a model 
to understand dynamic chromatin changes during Th2 cell differentiation, less is known 
about the Ifng locus. The promoter region of the Ifng gene is necessary for Ifng 
transcription. During transcription, DNase I hypersensitivity sites, histone acetylation and 
H3K4 dimethylation at the promoter region are significantly increased in a Th1 cell 
specific manner (81, 90), (85, 91). Th1 lineage specific transcription factors, T-bet and 
STAT4, have been demonstrated to bind to the proximal promoter of the Ifng gene and 
induce Ifng transcription (30), (31), (38) (Figure 1.6). However, studies of the proximal 
promoter and short upstream regions of the Ifng gene suggest that such elements are not 
sufficient for proper T cell specific expression. For instance, although it has been found 
that the immediate 108 bp 5’ flanking sequence of the human IFNG promoter contains 
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two regulatory elements (92), and that these elements are necessary for activation-
induced promoter function in both transient transfected Jurkat cells and primary human T 
cells, transgenes containing the Ifng promoter, Ifng introns and up to 3.4 kb of 5’ flanking 
sequence of the Ifng gene, do not direct robust Th1 specific IFN-γ expression in vivo (93, 
94). In contrast, transgenic studies using a 191 kb bacterial artificial chromosome 
containing 90 kb of 5’ and 3’ human IFNG-flanking sequence achieved high levels of 
Th1 specific human IFN-γ expression in murine T cells (94). These results suggest that 
distal transcription regulatory elements are dispersed in an extended region of over 100 
kb surrounding the gene are required for the proper expression of Ifng transcripts. 
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Figure 1.6 Map of murine Ifng locus.  
Conserved noncoding sequence (CNS) elements and their associated transcription factors 
at the Ifng locus are depicted.  
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Figure 1.6 
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Using large-scale cross-species DNA sequence comparison, several conserved noncoding 
regions near the Ifng gene have been identified. CNS-5 (or CNS1), which is located 5 kb 
upstream of the Ifng transcription initiation site, was discovered by two groups: Rao (95) 
and Wilson (90). This region has Th1-specific inducible DNase I hypersensitivity sites 
and significantly higher H3K4 methylation in Th1 cells compared with Th2 cells, which 
indicates a Th1-specific accessible chromatin structure at this region (95). T-bet and 
NFAT, the two transcription factors that are essential for Th1 differentiation, have been 
found to bind to CNS-5, suggesting that this region might regulate IFN-γ expression 
through interaction with these transcription factors (95) (Figure 1.6). Transient 
transfection assays show that this element has clear enhancer activity (90).  
 
CNS+18 (CNS2) was identified by Wilson and colleagues (90). CNS+18 is located 18 kb 
downstream of the transcription initiation site of the Ifng gene. Like CNS-5, this region 
has strong enhancer activity for Ifng gene expression and acts synergistically with CNS-5. 
In Th1 cells, histone acetylation, H3K4 dimethylation and DNase I hypersensitivity sites 
are dramatically increased at this region, and these favorable transcriptional 
modifications are parallel to Ifng mRNA expression. T-bet is able to bind to this region, 
although the binding is weaker in comparison to CNS-5 (90) (Figure 1.6). A chromosome 
conformation capture (3C) assay shows that CNS-5 and CNS+18 interact with the 
proximal promoter region of the Ifng gene, presumably by looping (96). 
CNS-22 is located 22 kb upstream of the Ifng transcriptional start site (91, 97). A 
promoter-reporter assay that coupled this element to the proximal Ifng promoter shows a 
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T-bet-dependent substantial increase in IFN-γ expression. A bacterial artificial 
chromosome transgenic reporter system demonstrates that conditional deletion of the 
CNS-22 element resulted in nearly complete loss of reporter expression in Th1 cells, 
cytotoxic T lymphocytes and NK cells. These data indicate that this single distal element 
may be essential for Ifng gene expression in both the adaptive and innate immune 
response. In contrast to other CNS elements, CNS-22 exhibits histone hyperacetylation in 
both Th1 and Th2 cells and contains a cluster of binding sites for transcription factors 
that are known to be important in Th1 and Th2 lineage determination, such as T-box 
factor, STAT, GATA, IRF, NF-κB and Ikaros. Among these transcription factors, T-bet 
has been demonstrated to bind to CNS-22 in both resting and stimulated Th1 cells (Figure 
1.6). This suggests that CNS-22 may function as an activator or silencer in distinct 
lineages. In addition, naïve CD4+ T cells display approximately twice the acetylated 
histones at the CNS-22 region in comparison to other sites examined, suggesting that this 
region may represent a chromatin entry site for transcription factors to carry out their 
functions (91, 98). 
 
CNS-34 was identified by Weaver and colleagues (91) and exhibits increased acetylation 
in Th1 cells,  and is bound by T-bet (91) (Figure 1.6). Although CNS-34 has T-bet-
dependent Ifng enhancer activity in vitro, its in vivo function needs to be elucidated.  
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Jak-STAT pathway 
As discussed above, cytokines are involved in the growth and differentiation of numerous 
cell types. They act by binding to specific receptors, which generally lack intrinsic 
tyrosine kinase activity and function through receptor-assocated kinases to mediate 
phosphorylaiton events. The Janus kinases are a family of receptor-associated tyrosine 
kinases that, together with STAT proteins, provide a rapid signaling pathway for 
cytokines. In general, cytokine receptor engagement recruits associated Jaks and results 
in Jak activation through auto-phosphorylation and trans-phosphorylation. Activated Jaks 
phosphorylate receptors to create docking sites for signaling proteins that have Src 
homology 2 (SH2) domains. Inactive STAT monomers bind to the phosphorylated 
receptors through their SH2 domain and are themselves phosphorylated by Jaks. 
Phosphorylated STATs dissociate from receptors, form dimers and subsequently 
translocate into the nucleus to induce gene transcription (Figure 1.7). 
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Figure 1.7 Jak-STAT pathway.  
Binding of cytokines to their individual receptors activates specific Jaks, which in turn 
phosphorylate tyrosine-based docking sites on the receptors. STAT monomers bind to the 
docking site through SH2 domain, get phosphorylated, form dimers, and then translocate 
into the nucleus, where they bind and activate specific target genes.  
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Figure 1.7 
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Four different Janus tyrosine kinases (Tyk2, Jak1, Jak2 and Jak3) have been identified 
and share significant structural homology with each other. Jaks have seven Janus 
homology (JH) domains (Figure 1.8). JH1 is a C-terminal kinase domain that is preceded 
by a pseudokinase domain, JH2. The psuedokinase domain has crucial regulatory activity 
without catalytic functions. The amino terminus of the Jaks comprises four JH domains 
(Half of JH4 and JH5-7) that are designed as FERM (four point one, ezrin, radixin, 
moesin) domain. The FERM domain mediates the association of Jaks with proline-rich 
regions on receptors. The first link between Jaks and cytokine signaling was made in 
1992 when it was found that Tyk2 mediates signaling from the IFN α/β receptor to 
cytoplasmic transcription factors through analysis of Tyk2-mutant cell lines (99). 
Thereafter, it has been reported that Jaks are associated with a number of cytokine 
receptors and their special and essential functions are clarified by studying Jak knockout 
or conditional knockout mice (100). 
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Figure 1.8 Structure of Jak and STAT.  
Regions of homology shared by Jaks have been termed Jak homology (JH) domains. JH1 
is a kinase domain and JH2 is a pseudo-kinase domain. FERM domain consists half of 
JH4 and JH5-7. Stats have seven essential domains, including a transcriptional activation 
domain (TAD), a tyrosine activation domain (Y), an SH2 domain, a helical linker domain 
(HLD), a DNA binding domain (DBD), a coiled-coil domain and a NH2 domain.  
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Figure 1.8 
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Seven STAT family members have been identified so far, each of which is composed of 
seven essential domains (Figure 1.8). These domains include a transcriptional activation 
domain (TAD) that is the most variable region and promotes gene transcription, a 
tyrosine activation domain (Y) that is phosphorylated by Jaks, an SH2 domain that binds 
to specific receptors, a helical linker domain (HLD) that ensures appropriate 
conformational changes upon the dimerization damain binding to DNA, a DNA binding 
domain (DBD) that is conserved among the STAT family members and directs binding to 
the γ interferon-activated site (GAS), a coiled-coil domain that binds the regulator 
proteins, and an NH2 domain that is involved in homotypic dimerization of inactive 
STATs, DNA binding, and the nuclear import or export process. STAT’s specificity is 
largely determined by the binding preference of their SH2 domains to certain docking 
sites on cytokine receptors, although cell type and differentiation state also contribute. In 
addition, forming heterodimers, tetramers and other higher order complexes expand the 
range of STAT/DNA binding specificities (101) 
 
The Jak-STAT pathway provides a rapid signal that is tightly controlled by various 
regulatory systems to avoid excessive simulation. These regulatory molecules include 
protein tyrosine phosphatases (102-104), suppressors of cytokine signaling (SOCS) (105) 
and protein inhibitors of activated STATs (PIAS) (106). In addition, endosomal 
degradation of Jak/receptor complexes through receptor-mediated endocytosis (107) 
(108), ubiquitination (109) and nuclear export also play a role in regulating Jak-STAT 
signal strength (110), (111).  
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Jak3 
In contrast to other Jaks that are ubiquitously expressed in tissues, Jak3 is preferentially 
expressed in hematopoietic cells, where it associates specifically with the common 
gamma chain (γc) that is shared by the receptors for γc cytokines, such as IL-2, IL-4, IL-7, 
IL-9, IL-15 and IL-21. These cytokines are crucial for the development, homeostasis, 
effector function and memory generation of immune cells. 
 
The function of Jak3 has been illustrated by analysis of Jak3 knockout mice generated by 
several groups (112-114). These mice have severe combined immunodeficiency (SCID) 
that resembles the phenotype of γc mutant mice. Jak3 knockout mice have very small 
thymuses, absence of lymph nodes, no NK cells or γ/δ T cells and reduced number of α/β 
progenitor cells. Analysis of the peripheral cells in Jak3-deficient mice shows that there 
are few CD8+ T cells and normal number of CD4+ T cells. However, the majority of 
CD4+ T cells have activated or memory phenotype and are CD4+ CD44high CD62Llow. In 
contrast to SCID patients, the number of B cells in Jak3 knockout mice is also profoundly 
decreased (112-114). 
 
The phenotype observed in Jak3-deficient mice can be readily interpreted by the ever-
growing knowledge of cytokine biology through inactivating γc cytokines or γc cytokine 
receptors. The absence of NK cells in Jak3-deficient mice can be explained by the failure 
of IL-15 signaling. IL-15 knockout mice lack NK cells, suggesting IL-15 is critical for 
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the development and survival of these cells (115), (116, 117). The lymphocyte defects in 
Jak3 knockout mice are mostly explained by the deficiency of IL-7 signaling. IL-7 is 
critical for early lymphocyte development through two signals. One signal is for the 
proliferation and survival of lymphocyte precursors by inducing the expression of anti-
apoptosis factor Bcl2 and activating phosphatidylinositol (PI3) kinase (118, 119). The 
other signal is for generation of lymphocyte precursors by promoting V(D)J 
recombination of TCR and Immunoglobulin genes (120-122). Therefore, in mice lacking 
IL-7, IL-7R or Jak3 mice, γ/δ T cells fail to develop, B cell development is blocked at 
pro-B stage and α/β T cell progenitors are nearly absent. In addition to lymphopoiesis, 
IL-15 and IL-7 are important for the homeostatic proliferation of naïve and memory 
CD8+ T cells (123, 124) and naïve CD4+ T cells (125). However, the proliferation of 
memory CD4+ T cells is less dependent on both cytokines (126). This may explain the 
phenotype of fewer CD8+ T cells but more memory-like CD4+ T cells in the periphery of 
Jak3 knockout mice.  
 
Although phenotypically the majority of peripheral T cells in Jak3 knockout mice are 
activated- or memory-like cells, their function is unique. First, they fail to proliferate and 
have impaired survival in response to stimulation in vitro (112, 127). Second, they 
produce little IL-2 or IL-4, but produce IL-10, IFN-γ and TGF-β instead when stimulated 
in vitro (128). Third, they modestly suppress the proliferation of wild type CD4+ T cells 
in coculture assays (128). Taken together, CD4+ T cells in Jak3 knockout mice display 
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the features of regulatory T cells, indicating that Jak3 is not critical for directing CD4+ T 
cell differentiation into a regulatory lineage.  
 
As detailed above, CD4+ T cells in mice lacking Jak3 have undergone an alternative 
pathway of differentiation. To investigate the role of the Jak3/γc pathway in naïve CD4+ 
T cell activation, homeostatic proliferation and effector function, Di Santo and colleagues 
crossed γc-deficient mice to TCR transgenic mice to generate naïve CD4+ T cells. They 
found that in contrast to memory T cells, naïve CD4+ T cells cannot survive in the 
absence of γc signaling (125). This survival defect is able to be rescued by 
overexpression of human BCL2 (129). The proliferation of naïve CD4+ T cells is 
independent of γc signals both in vivo (125) and in vitro (129, 130), which challenged the 
old dogma that IL-2 and IL-4 are T cell growth factors.  This group also demonstrated 
that γc cytokines are involved in the full differentiation of CD4+ T cells in vivo by 
providing the evidence that γc-deficient CD4+ T cells fail to reject the skin graft and have 
defects in producing IFN-γ or granzyme B (130). The mechanisms remain unclear.  
 
STAT5 and the mechanisms of its transcriptional activation 
The predominant STAT that is activated by γc cytokines is STAT5. Encoded by two 
distinct but closely related genes, the two isoforms of this transcription factor, STAT5a 
and STAT5b, are 91% identical at the amino acid level with the extreme carboxyl-
terminal transactivation domain showing the most divergence. However, their 
physiological functions are not fully redundant. For example, STAT5a knockout mice 
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display a profound defect in adult mammary gland development and lactogenesis (131), 
whereas STAT5b-deficient mice exhibit defects related to growth hormone actions (132). 
Both STAT5a and STAT5b knockout T cells show decreased proliferation in response to 
stimulation, although the defect in the cells lacking STAT5b is more severe (133, 134). 
Both STAT5a and STAT5b contribute to normal NK cell development with a greater 
defect in NK cell function seen in STAT5b knockout mice (134). In general, with respect 
to immune system, deficiency of STAT5a or STAT5b alone does not develop severe 
defects. STAT5ab double knockout mice have severely impaired lymphocyte 
development, survival and function, resembling the phenotype of Jak3 and γc knockout 
mice (135). These suggest that these two closely related isoforms regulate the expression 
of some distinct target genes as well as the identical ones.  
 
The molecular mechanisms by which STAT5 promotes gene transcription have been 
studied. Initially, STAT5 was shown to have transactivation activity by binding to GAS 
and associating with several cofactors such as p300/CBP, N-myc interactor (Nmi), 
protein inhibitors of activated STAT (PIAS), and SMRT. P300/CBP and Nmi have been 
reported to potentiate STAT5 mediated transactivation, whereas PIAS and SMRT down-
modulate expression of STAT5 target genes (136, 137). Therefore, STAT5-interacting 
proteins are able to function as positive or negative factors to regulate STAT5 signaling 
and contribute to the specificity and complexity of STAT5-mediated gene activation. 
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Some STAT5 cofactors have histone modification activity, which implicates STAT5 in 
chromatin regulation during cytokine-induced transcription. For instance, it is known that 
p300/CBP has intrinsic histone acetyltransferase activity (138, 139), and SMRT recruits 
HDACs to cause transcriptional repression (140, 141). Recently, STAT5 itself has also 
been shown to have chromatin remodeling activity. Studies in B cells and γδ T cells have 
shown that STAT5 directly regulates chromatin remodeling by promoting histone 
acetylation of genes including CIS (142), the distal VHJ558 gene (122) and the TCRγ 
locus (143).  In addition, STAT5 interacts with SWI/SNF chromatin remodeling factors 
on the β- and γ-casein promoters in mammary epithelial cells following prolactin plus 
extracellular matrix protein stimulation (144). Whether the chromatin remodeling activity 
of STAT5 is the direct result of STAT5/DNA binding or the recruitment of a chromatin 
remodeling complex by STAT5 remains to be elucidated.  
 
Work presented in this thesis 
The goal of my thesis is to further understand the importance of γc cytokines in T cell 
immunity. Specifically, we investigated the role of γc cytokines in CD4+ T lymphocyte 
proliferation, survival and differentiation. Using naïve T cells lacking Jak3-dependent 
cytokine signals, we demonstrate that although Jak3-dependent cytokine signals are 
dispensable for CD4+ T cell proliferation, they are indispensable for CD4+ T cell 
differentiation and survival. This work elucidates the differential mechanisms regulating 
clonal expansion, survival and effector function of T cells. Furthermore, this work 
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identified a novel mechanism by which Jak3-STAT5 pathway regulates Th1 
differentiation. 
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CHAPTER II 
Janus-Kinase-3-Dependent Signals are not 
Required for the Cell Cycle Progression of Naïve 
CD4+ T Cells 
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Introduction 
T cell proliferation is essential for mounting an effective adaptive immune response. A 
key element of proliferation is the entry of cells into the cell cycle, a complex process 
that is tightly controlled by the ordered expression of cyclins, the activation of cyclin-
dependent kinase (Cdk) enzymatic activity and the subsequent phosphorylation of 
relevant substrates. The first cyclin expressed during the G1 phase is a D-type cyclin, 
which is a rate-limiting factor for cell cycle progression from the G1 to the S phase. The 
induction of cyclin E occurs at the late G1 restriction point, and cyclin A is expressed at S 
phase entry (145). The activity of Cdks is stimulated by cyclins and inhibited by cyclin-
dependent kinase inhibitors (CDKI), such as p27kip1. Cyclin/Cdk complexes 
phosphorylate the retinoblastoma (Rb) gene product, leading to the activation of the E2F 
transcription factor, which is required for the transcription of S phase genes. 
 
T cell proliferation is induced following stimulation of the T cell receptor (TCR) and 
costimulatory molecules; in addition, cytokines such as IL-2 and IL-4, that signal through 
receptors sharing the common γ (γc) chain, have been shown to promote lymphocyte 
proliferation (146). Among these, IL-2 has long been recognized as the most potent T cell 
growth factor (147). In vitro studies have shown that IL-2 very efficiently promotes the 
growth of antigen-activated T cells (148, 149). Antigen- or mitogen-induced T cell 
proliferation in vitro can be substantially inhibited using monoclonal antibodies specific 
for IL-2 or the IL2R, suggesting that IL-2 is an essential element in T cell proliferation 
(150-152). In later studies, it was found that IL-2 promotes the transit of T cells through 
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G1 to S phase of the cell cycle by up-regulating cyclin D2, cyclin D3, cyclin E and E2F, 
and down-regulating p27kip1 (153-156). Based on these findings, among others, the 
consensus view is that TCR and CD28 stimulation induce quiescent T cells to leave G0 
and enter the G1 phase of the cell cycle (157); in addition, these signals induce the 
expression of the high-affinity IL-2 receptor and stabilize the IL-2 message, rendering the 
cells competent for IL-2-driven proliferation.  
 
Recent studies performed in intact animals have challenged this view and demonstrated 
IL-2- or γc cytokine-independent T cell expansion in vivo. When adoptively-transferred, 
IL-2-deficient or IL-2R-deficient DO11.10 T cells challenged with OVA peptide 
underwent comparable expansion compared to wild type T cells (158, 159). Similarly, 
after correcting the autoimmune defect in IL-2Rβ-deficient mice by selective expression 
of IL-2Rβ in the thymus, IL-2R β-/- T cells also showed normal expansion during both 
primary and secondary immune responses (30). Finally, Di Santo and colleagues reported 
that naïve γc chain-deficient T cells proliferate robustly in response to antigenic 
stimulation in vivo (125). Together, these results indicate that γc cytokine signals are not 
absolutely required in vivo for T cell proliferation.   
 
Several in vitro studies also suggest that T cell proliferation can occur in an IL-2-
independent manner. For instance, except under conditions of suboptimal stimulation, IL-
2 or IL-2R antibody blockade cannot completely inhibit T cell proliferation (73, 160). 
Further, IL-2- or IL-2R-deficient T cells can be induced to proliferate in response to 
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specific antigens or mitogens, although the proliferation is generally reduced compared 
with that of control T cells (161-164). Finally, several studies have suggested that TCR 
plus CD28 stimulation controls cell cycle progression independently of IL-2. Using IL-2 
or IL-2R blocking antibodies, or IL-2-deficient cells, these studies indicated that 
TCR/CD28 engagement could promote T cell proliferation by inducing the expression of 
cyclin D and cyclin E, enhancing the transcriptional activity of E2F, and down-regulating 
the inhibitory function of p27kip1 (165-171).  
 
However, there are a number of caveats with these studies that have hampered the 
general acceptance of the view that T cell proliferation does not require IL-2 or other γc 
cytokine signals. First, the failure to completely block T cell proliferation with IL-2 or 
IL-2R antibodies may reflect the lower affinity of these interactions relative to the 
affinity of IL-2 for its receptor. Second, several of these studies were performed using 
tumor cell lines or anergic T cells, which may not reflect the requirements of primary 
naive T cells. A similar concern applies to the studies using IL-2- or IL-2R-deficient T 
cells, as these cells are also not naïve T cells (158). Finally, these in vitro studies did not 
rule out the possibility that T cell proliferation was being induced by γc cytokines other 
than IL-2; although IL-2 is the main γc cytokine that is secreted when T cells are initially 
activated in vitro, IL-4 and IL-21 are also produced by activated T cells and can promote 
T cell proliferation (172-174). Therefore, none of these studies conclusively 
demonstrated that naïve T cell proliferation was γc cytokine-independent. 
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In this report, we investigated the requirement of γc cytokines in the proliferation and cell 
cycle control of primary naïve T cells in vitro. We analyzed the proliferation of naïve 
CD4+ T cells from the mice lacking Janus kinase 3 (Jak3), a tyrosine kinase that is 
essential for signaling via all γc cytokine receptors. We complemented these experiments 
with analysis of wild type naïve CD4+ T cells treated with a pharmacological inhibitor of 
Jak3. Together, these studies demonstrated that Jak3-dependent γc cytokine signals are 
not required for naïve primary CD4+ T cell proliferation and cell cycle regulation in vitro.  
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Results 
Jak3-dependent cytokine signals are required for optimal T cell responses in vitro. 
As mentioned in the introduction part of this thesis, the majority of CD4+ T cells in Jak3-/- 
mice have an activated or memory phenotype. To investigate the potential role of Jak3-
dependent cytokine signals in naïve T cell proliferation, we established an in vitro assay 
system using homogenous populations of naïve Jak3-/- CD4+ T cells. Previous work has 
generated naïve CD4+ peripheral T cells by crossing Jak3-/- mice to TCR transgenic mice 
(125). Here, we crossed Jak3-/- mice to the transgenic line expressing the OT-II TCR to 
obtain Jak3-/- CD4+ T cells with a receptor specific for OVA peptide presented by the 
MHC class II molecule I-Ab. The majority of peripheral CD4+ T cells in these mice have 
a naïve phenotype. However, the absolute number of T cells is greatly reduced. Since γc 
cytokines are required for naïve CD4+ T cell survival in vivo mainly through the function 
of Bcl-2 (125), we also introduced a transgene expressing Bcl-2. The resulting Jak3-/- 
OT-II Bcl-2 mice have a large number of peripheral CD4+ T cells which are CD44lo. 
Purified CD4+ CD44lo T cells from Jak3+/- or Jak3-/- OT-II Bcl-2 mice were stimulated 
with varying concentrations of OVA peptide presented by mitomycin C-treated antigen 
presenting cells (APCs) from C57BL/6 mice (Figure 2.1a) or anti-CD3 and anti-CD28 
antibodies (Figure 2.1b). As shown, Jak3-/- CD4+ CD44lo T cells were capable of 
proliferating in response to all stimuli, although the magnitude of the response was 
reduced in comparison to that of control cells. This reduced proliferation of Jak3-/- T cells 
could result from impaired T cell proliferation or impaired T cell survival, or both.  
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Figure 2.1 CD4+ T cell proliferation appears reduced in the absence of Jak3-
dependent cytokine signals.  
CD4+CD44lo T cells were sorted from Jak3+/- and Jak3-/- OT-II Bcl-2 mice and stimulated 
with either mitomycin C-treated C57BL/6 APCs plus the indicated concentrations of 
OVA323-339 (a) or various concentrations of anti-CD3 and anti-CD28 antibodies (b) for 
48h, then pulsed with [3H]-thymidine for the final 18h. Cell proliferation was measured 
by [3H]-thymidine incorporation. Data represent the mean ± SE of the triplicate reactions. 
Statistically significant differences were seen between Jak3+/- and Jak3-/- cells. The 
significant level is P < 0.05. 
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Figure 2.1 
  
65
T cell proliferation is not affected by Jak3-dependent cytokines, but survival is 
γc cytokines, especially IL-2, IL-4 and IL-7, promote T cell survival by up-regulating the 
anti-apoptotic factor Bcl-2 (175-178). In Jak3- or γc-deficient T cells, the expression of 
Bcl-2 is greatly decreased (125), (70). To determine whether constitutive expression of 
Bcl-2 is sufficient to reverse the survival defect of Jak3-/- T cells in vitro, we examined T 
cells for evidence of apoptosis. For these studies we used CD4+CD8- single-positive 
(CD4SP) thymocytes from Jak3+/- or Jak3-/- OT-II Bcl-2 mice as a source of 
homogeneous naïve T cells. Following 3 days of stimulation, cells from Jak3-/- mice 
showed a significantly higher degree of cell death compared to control cells (Figure 2.2a). 
These findings indicate that Jak3-dependent cytokine signals normally induce a survival 
pathway that cannot be compensated for by constitutive expression of Bcl-2. Thus, in the 
absence of Jak3, the reduced level of 3H-thymidine incorporation following T cell 
activation may be due to enhanced apoptosis, rather than impaired proliferation. 
 
T cell proliferation can be assessed using the fluorescent dye, carboxyfluorescein 
succinimidyl ester (CFSE), providing a means of excluding dead cells in the population 
and of visualizing the proportion of cells representing each successive cell division cycle.  
As can be seen, after 3 days of stimulation with anti-CD3 and anti-CD28 antibodies, there 
was no significant difference in the percentage of divided cells between Jak3-deficient 
and Jak3-positive T cells, suggesting that Jak3-dependent cytokine signals do not regulate 
the proportion of cells entering the cell cycle (Figure 2.2b, c). To examine this issue more 
carefully, we determined the percentage of cells in each round of cell division, and 
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compiled the data from four independent experiments (Figure 2.2d). This analysis 
confirmed that T cells lacking Jak3 showed comparable proliferative capacity to T cells 
expressing Jak3. Similarly, a comparison of the proliferation index as well as the division 
index between the two populations of T cells indicated no significant differences in the 
average number of divisions that cells of each genotype underwent. Taken together, these 
data indicate that Jak3-dependent cytokine signals are not required for naïve T cell 
proliferation in vitro, but are important in maintaining maximum T cell survival. 
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Figure 2.2 Jak3-dependent cytokine signals affect T cell survival but not 
proliferation.  
(a) Purified CD4SP thymocytes from Jak3+/- and Jak3-/- OT-II Bcl-2 mice were 
stimulated with anti-CD3 (1 μg/ml) plus anti-CD28 (4 μg/ml) antibodies. Three days 
later, cells were stained with AnnexinV and 7-AAD, and analyzed by flow cytometry.  
Apoptotic cells were identified as AnnexinV+ 7-AAD+. 
(b, c, d) CD4SP thymocytes were isolated from Jak3+/- and Jak3-/- OT-II Bcl-2 mice, 
labeled with CFSE, stimulated with anti-CD3 (1 μg/ml) plus anti-CD28 (4 μg/ml) 
antibodies, and analyzed by flow cytometry. b) representative histograms show the 
degree of CFSE dilution in Jak3+/- and Jak3-/- OT-II Bcl-2 T cells. c) Percentage of 
Jak3+/- and Jak3-/- OT-II Bcl-2 T cells that underwent cell division; data represent the 
mean ± SE from four independent experiments. d) Histograms were analyzed using the 
proliferation platform of the FlowJo software to estimate the percentage of cells in each 
round of cell division; representative data are shown above. The graph depicts the mean ± 
SE using data from four independent experiments.  No significant differences were seen 
between Jak3+/- and Jak3-/- cells. 
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Figure 2.2 
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Pharmacological inhibition of Jak3 impairs T cell survival, but not proliferation 
To rule out the possibility that Jak3-/- T cells are developmentally abnormal, leading to 
their independence from Jak3-dependent cytokine signals for T cell proliferation, we 
examined the responses of Jak3+/+ CD4+ T cells treated with a small molecule inhibitor of 
Jak3, PS078507 (179). Compound PS078507 was developed by Pharmacopeia, Inc. 
(Princeton, NJ), and had an IC50 of 2.1nM for inhibition of Jak3 enzyme activity (Figure 
2.3a). Inhibitory activity (IC50) on the other Jak kinases was measured at 20nM, 6.3nM, 
and 12nM for Jak2, Jak1, and Tyk2, respectively, and was >300nM on a panel of 30 
additional kinases tested (data not shown). In a cellular assay examining inhibition of IL-
2-induced proliferation of human peripheral blood T cells, the IC50 is 73nM (Figure 
2.3b). The optimal concentration of PS078507 for Jak3 inhibition in murine peripheral 
CD4+ T cells was determined by examining IL-2-induced STAT5 phosphorylation 
(Figure 2.3c).  
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Figure 2.3 Characterization of the Jak3 inhibitor, PS078507 
(a) Structure of the Jak3 inhibitor, PS078507.  
(b) Various concentrations of PS078507 were included in the JAK3 kinase and cell 
proliferation assays as described below.  Each compound dilution was tested in duplicate.  
The average IC50 values ± S.D for inhibition of human JAK3 kinase activity and IL-2-
induced PBMC proliferation by PS078507 are 2.1±0.4 nM (n=3) and 73±30 nM (n=5), 
respectively.  
(c) CD4+ T cells were isolated from Jak3+/+ mice, stimulated with anti-CD3 and anti-
CD28 antibodies for 2 days, rested for 4 hours, incubated with vehicle alone or serial-
diluted PS078507 for 30 minutes, then stimulated with IL-2 (50 ng/ml) for 15 minutes.  
Cell lysates were prepared and immunoblotted for pSTAT5 and β-actin.  
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Figure 2.3 
PS078507 
c 
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The effect of PS078507 on cell survival was then assessed following 3 days of in vitro 
stimulation. As shown, naïve Jak3+/+ CD4+ T cells from OT-II transgenic mice displayed 
dramatically higher levels of  apoptosis in the presence of the inhibitor, regardless of the 
expression of Bcl-2 (Figure 2.4a). Consistent with the data shown above using Jak3-/- T 
cells, when cell proliferation was determined using CFSE dilution, Jak3+/+ naïve CD4+ T 
cells treated with PS078507 showed a comparable proportion of divided cells compared 
to cells treated with vehicle alone (Figure 2.4b).  Further, the percentage of divided cells 
in each successive cell division cycle also showed no significant difference compared to 
controls, when averaged over four independent experiments (Figure 2.4c). Together, 
these data indicate that cell survival, but not proliferation, is regulated by Jak3-dependent 
cytokine signals. 
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Figure 2.4 CD4+ T cell survival but not proliferation is reduced by pharmacological 
inhibition of Jak3 activity.  
(a) Purified CD4+ splenocytes from OT-II-transgenic or OT-II Bcl-2-transgenic mice 
were stimulated with anti-CD3 (1 μg/ml) and anti-CD28 (4 μg/ml) antibodies for 3 days 
in the presence of vehicle alone or PS078507 at 312 nM, stained with AnnexinV and 7-
AAD, and analyzed by flow cytometry. Apoptotic cells were identified as AnnexinV+ 7-
AAD+. 
(b, c) Purified CD4+ splenocytes from OT-II-transgenic mice were labeled with CFSE 
and stimulated with anti-CD3 and anti-CD28 antibodies for 3 days in the presence of 
vehicle alone or PS078507 at 312 nM, and then analyzed by flow cytometry. c) 
Histograms show CFSE fluorescence. The bar graph indicates the percentage of T cells 
undergoing division in the absence or presence of PS078507; data show the mean ± SE 
compiled from four independent experiments. d) Histograms were analyzed using the 
proliferation platform of the FlowJo software to estimate the percentage of cells in each 
round of cell division; representative data are shown above. The graph depicts the mean ± 
SE using data from four independent experiments. No significant differences were seen 
between cells stimulated in the presence or absence of the Jak3 inhibitor.  
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Figure 2.4 
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Cell cycle regulation is independent of Jak3 signaling 
The precise function of TCR/CD28 signaling versus cytokine signaling in regulating 
naïve CD4+ T cell proliferation in vitro remains ambiguous. To address this issue, we 
examined cell cycle progression of naïve T cells stimulated in the presence or absence of 
the Jak3 inhibitor, PS078507. Jak3+/+ CD4+ T cells from OT-II transgenic mice were 
stimulated, harvested at a variety of timepoints, and analyzed for DNA content using 
propidium iodide (PI). The intensity of the PI signal is directly proportional to DNA 
content, with the rightmost peak on the histogram representing the cells in the G2/M 
phase, the leftmost peak showing the cells in the G0/G1 phase, and the area between the 
two peaks indicating the cells within the S phase (Figure 2.5a). To compare cell cycle 
progression between samples, we calculated the percentage of live cells in each phase, 
and averaged the data from three independent experiments (Figure 2.5b). This analysis 
indicated that CD4+ T cells lacking Jak3-dependent cytokine signals have 
indistinguishable cell cycle kinetics relative to cells receiving these cytokine signals (P > 
0.05).  
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Figure 2.5 Cell cycle progression is not affect by Jak3 inhibition.  
Purified CD4+ splenocytes from OT-II-transgenic mice were stimulated with anti-CD3 
and anti-CD28 antibodies in the presence of vehicle alone or PS078507 at 312 nM. At the 
indicated time points, cells were harvested, fixed, stained with propidium iodide (PI) and 
analyzed by flow cytometry. A, Histograms represent the DNA content of the cells after 
stimulation in the presence of vehicle or PS078507. B, Percentage of cells in G0/G1, S 
and G2/M phase is indicated for each timepoint; data represent the mean ± SE compiled 
from three independent experiments. No significant differences were seen between cells 
stimulated in the absence versus the presence of the Jak3 inhibitor. 
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Figure 2.5 
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Cyclins and cyclin-dependent kinase inhibitors (CDKI) are the key regulators of cell 
cycle progression. The early stage of the G1 phase is regulated by D-type cyclins; in T 
cells, cyclin D2 is the first to be induced following activation (180). To examine cell 
cycle progression at the molecular level, we determined whether TCR and CD28 
stimulation could independently induce the expression of cyclin D2, in the absence of 
Jak3-dependent cytokine signals. As shown in Figure 2.6a, CD4 SP thymocytes from 
Jak3-/- OT-II Bcl-2 mice up-regulate cyclin D2 comparably to cells from control mice at 
day three of activation. Timepoint analysis further confirmed that the level of cyclin D2 
increased at 48h and peaked at 96h after activation in both Jak3+/- and Jak3-/- OT-II Bcl-2 
cells (Figure 2.6a, lower panel). Whereas cyclin D2 controls the entry of cells into the G1 
phase, passage through the G1 restriction point into the late G1 stage requires the 
induction of cyclin E. When we examined cyclin E expression, we also saw no difference 
between Jak3+/- and Jak3-/- OT-II Bcl-2 cells at 48h or 96h post-activation (Figure 2.6a). 
 
To drive cell cycle progression, cyclins associate with cyclin-dependent kinases to form 
active holoenzymes. These holoenzymes are inhibited by CDKIs; specifically, p27kip1, 
which is constitutively expressed in resting naïve T cells, inhibits the activities of 
cyclinD2/cdk4/6 and cyclinE/cdk2 (168). Therefore, cell cycle progression depends on 
the down-regulation of p27kip1, in addition to the up-regulation of cyclins. When levels 
of p27kip1 were examined in activated Jak3+/- and Jak3-/- OT-II Bcl-2 cells, we found 
that p27kip1 was undetectable in both cell types by 3 days post-stimulation (Figure 2.6a). 
Finally, we examined cyclin A, which is required for the cells to progress through S 
  
79
phase. Again, upregulation of cyclin A was comparable between Jak3+/- and Jak3-/- T 
cells (Figure 2.6a). The upregulation of cyclin A and the loss of p27kip1 were confirmed 
with wild-type T cells stimulated in the presence of the Jak3 inhibitor, PS078507. 
Furthermore, an extensive timecourse indicated no differences in the kinetics of these 
changes with or without Jak3-dependent cytokine signals (Figure 2.6b).  
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Figure 2.6 Cell cycle proteins are regulated normally in the absence of Jak3-
dependent cytokine signals.  
(a) Purified CD4SP thymocytes from Jak3+/- and Jak3-/- OT-II Bcl-2 mice were 
stimulated with anti-CD3 and anti-CD28 antibodies for 3 days (upper panel) or for 
indicated times (lower panel). Total cell lysates were prepared and immunoblotted for 
p85, cyclin D2, cyclin E, cyclin A and p27kip1. PI-3-kinase p85 was detected as a 
loading control.  
(b) Purified CD4+ splenocytes from OT-II-transgenic mice were stimulated with anti-
CD3 and anti-CD28 antibodies in the presence or absence of PS078507 at 312 nM. At the 
indicated time points, cells were harvested and total cell lysates were prepared and 
innunolotted for p85 (loading control), cyclin A and p27kip1.  
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Figure 2.6 
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CD28 costimulation substitutes for cytokine signals to drive T cell proliferation  
Our findings thus far indicated that Jak3-dependent cytokine signals are not required for 
T cell proliferation or cell cycle progression. However, it remained possible that 
cytokine-independent T cell proliferation requires strong TCR and/or CD28 stimulation. 
To examine whether Jak3-dependent cytokine signals are more essential under conditions 
of suboptimal T cell stimulation, we performed titration experiments in which the 
strength of TCR or CD28 stimulation was varied. As the anti-CD3 and anti-CD28 
antibodies were titrated down, a substantial reduction in T cell proliferation was observed.   
The inhibition of Jak3 activity had no effect at any of the conditions tested, nor did 
addition of exogenous IL-2 (Figure 2.7a). In a second set of experiments, the 
concentration of anti-CD28 antibody was fixed at 4 μg/ml and the anti-CD3 antibody was 
varied. As shown in figure 2.7b, T cell proliferation was largely unaffected by this wide 
range of TCR stimulation conditions, and was also independent of Jak3 signaling. Finally, 
we fixed the concentration of anti-CD3 antibody at 5 μg/ml and varied the concentration 
of anti-CD28 antibody. In the absence of the Jak3 inhibitor, CD4+ T cells proliferated 
robustly in response to each stimulation condition.  However, when CD28 stimulation 
was limiting, inhibition of Jak3-dependent cytokine signaling led to a marked inhibition 
of T cell proliferation (Figure 2.7c). These results indicate that optimal CD28 stimulation 
can replace Jak3-dependent cytokine signals to drive T cell proliferation, and further, that 
when CD28 costimulatory signals, but not TCR signals, are limiting, T cell proliferation 
becomes cytokine-dependent. 
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Figure 2.7 Jak3-dependent cytokine signals are required for T cell proliferation 
when CD28 costimulation is suboptimal.  
(a, b, c) Purified CD4+ splenocytes from OT-II-transgenic mice were labeled with CFSE 
and stimulated with indicated concentrations of anti-CD3 and anti-CD28 antibodies in the 
presence of vehicle alone or PS078507 at 312 nM, and then analyzed by flow cytometry.  
In (a), recombinant IL-2 was added at 10 ng/ml. Bar graphs show the percentage of T 
cells that divided without or with the treatment of the inhibitor.  Bar graphs represent one 
of the two independent experiments. 
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Figure 2.7 
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Discussion 
Generation of a pool of daughter cells from a small number of naïve T cells is an 
essential step for the adaptive immune response against pathogens. Following clearance 
of an infection, the expanded effector cells are eliminated to prevent the pathological 
accumulation of these potent cells. Thus, both cell proliferation and cell death must be 
tightly controlled to maintain the integrity of the immune system. In this report, we 
demonstrate that Jak3-dependent cytokine signals are not required for naïve CD4+ T cell 
in vitro proliferation; instead, they are critical for cell survival. Optimal TCR/CD28 
signaling, in the absence of cytokine signals, induces cell cycle progression by 
modulating cell cycle regulators, such as cyclins and p27kip1. However, we find that 
under suboptimal stimulation conditions, CD28 signaling is critical in promoting IL-2-
independent T cell proliferation.  
 
T cell proliferation is generally accompanied by cell death, an essential aspect of 
preventing the over-expansion of immune cells. However, during a productive immune 
response, the proliferating T cells must be temporarily protected from cell death. The role 
of γc cytokines in promoting the survival of resting T cells, and in maintaining the 
population of naïve T cells in vivo, is well established (129). However, evidence 
demonstrating that activated T cells can be killed by cytokine withdrawal also points out 
the key role of cytokine signals, in particular γc cytokine signals, in promoting the 
survival of activated T cells (181). This latter role of γc cytokine signals does not appear 
to be mediated solely through regulation of Bcl-2. Although constitutive expression of 
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Bcl-2 leads to the accumulation of nearly normal numbers of naïve resting CD4+ T cells 
in Jak3-/- or γc-/- mice (129, 179), Bcl-2 expression only partially reverses the impaired 
survival of activated Jak3-/- T cells.  
 
These data suggest that γc cytokine signals differentially regulate the survival of naïve 
versus activated CD4+ T cells. In this regard, a subgroup of Bcl-2 family proteins, the 
Bcl-2 homology (BH) 3-only proteins, play an essential role in activated T cell death 
(182, 183), leading to the conclusion that it is the ratio of BH3-only proteins (pro-
apoptotic) to Bcl-2-like proteins (anti-apoptotic) that determines whether activated T cells 
live or die (181). In a second mechnism, the NFκB-regulator/coactivator Bcl-3 has also 
been implicated in activated T cell death (184), (181).  Thus, Jak3-dependent cytokine 
signals acting in the first several days following T cell activation may prevent the 
upregulation of BH3-only proteins or induce the expression of Bcl-3. 
 
The issue of whether IL-2 is required for T cell proliferation has been a long-standing 
controversy. Initial experiments characterizing IL-2 demonstrated that this cytokine 
functions as a T cell growth factor, leading to the conclusion that IL-2 is crucial for T cell 
proliferation (147-149). More recent studies clearly indicate that T cells are capable of 
proliferating in the absence of IL-2R signals. However, the proliferative responses of IL-
2- or IL-2R-deficient cells to antigen stimulation are highly variable among experiments. 
Some experiments show that these responses are only 5-10% of control T cells (161, 185, 
186). Other experiments demonstrate that the proliferative responses of T cells lacking 
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IL-2 signals are 50% of control T cells, and that the replication of these cells is limited to 
only 2-3 rounds of cell division (164).  
 
In contrast to these earlier findings, our studies indicate that naïve T cell in vitro 
proliferation occurs independently of all γc cytokine signals, including IL-2. Further, we 
show that T cells lacking IL-2 signals are capable of undergoing at least 7 rounds of cell 
division in vitro. The discrepancy between our results and those reported previously is 
likely due to two factors. First, the traditional method used to measure T cell proliferation 
is by tritiated-thymidine incorporation. As this technique cannot distinguish between 
reduced proliferation and increased cell death, it is likely that the proliferative responses 
of T cells in the absence of IL-2 were underestimated in earlier studies. Second, some 
previous studies were performed with mixtures of naïve T cells and activated/memory T 
cells.  Since activated/memory T cells may be more dependent on IL-2 for clonal 
expansion, this may also have led to conclusions not entirely applicable to naïve CD4+ T 
cells.   
 
Since IL-2 is not the sole cytokine secreted by activated T cells, we expanded our study 
to simultaneously assess the role of all γc cytokines in T cell proliferation by targeting the 
downstream kinase, Jak3, required for all of these receptor signaling pathways. Our 
results, that naïve CD4+ T cell proliferation is independent of cytokines, are consistent 
with a recent paper from Di Santo and colleagues, who reported robust in vitro 
proliferation of γc-/- T cells (129). These data indicated that signaling through the TCR 
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plus CD28 is sufficient to induce T cell proliferation. However, this latter study limited 
their analysis to examining CFSE profiles of T cells at day 4-6 post-activation.  No 
examination at early timepoints after activation, no cell cycle analysis, no biochemical 
analysis of cell cycle regulators, and no assessment of the differential roles of TCR 
versus CD28 signaling were included in this former study.  Thus we have extended these 
previous findings with a more thorough examination of cell cycle progression in the 
absence of Jak3-dependent cytokine signals, and have also discovered an important role 
for cytokines when costimulatory signals are limiting. 
 
Past studies using IL-2 and IL-2R blocking antibodies or IL-2-deficient cells, have shown 
that TCR/CD28 stimulation directly promotes the upregulation of cyclins and the 
downregulation of p27kip1. However, in these studies it was difficult to determine 
whether the blocking antibodies were able to completely inhibit IL-2R signaling, and in 
addition, activated T cells secrete other γc cytokines that may contribute to the regulation 
of cell cycle proteins. Therefore, we examined this issue using two approaches, each of 
which leads to complete inhibition of all γc cytokine signaling pathways. Our results 
indicate that a genetic deficiency in Jak3, or pharmacological inhibition of Jak3, have no 
effect on cell cycle progression following optimal stimulation of the TCR plus CD28.  
Upregulation of cyclin D2, cyclin E and cyclin A, as well as downregulation of P27kip1, 
are indistinguishable in the presence versus the absence of cytokine signaling. This 
conclusion was also confirmed by a timecourse of cell cycle analysis quantitating the 
progression of cells through each phase of the cell cycle. 
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In our system, we analyzed the role of Jak3-dependent signals in CD4+ T cell through in 
vitro proliferation system. In the absence of Jak3-dependent signals, we used a transgene 
expressing Bcl-2 to rescue the in vivo survival defect of naïve CD4+ T cells. It has been 
shown that over-expression of Bcl-2 might have anti-proliferative function, especially 
under suboptimal conditions (187). This anti-proliferative affect could confound our 
studies, although this trangene was used in both Jak3-/- and wild type mice. However, 
under our in vitro simulation conditions (anti-CD3 1μg/ml plus anti-CD28 4μg/ml), we 
did not observe any proliferative difference in CD4+ T cells from wild type and Bcl-2 
transgene mice (data not show). Further, analysis of wild type CD4+ T treated with or 
without a Jak3 inhibitor showed similar results. Therefore, using the Bcl-2 transgene in 
our system does not affect the in vitro proliferation of naïve T cells.  
 
Another potential caveat to our system is that the high concentration of anti-CD3 and 
anti-CD28 used during in vitro priming of T cells may not mimic in vivo responses.  In 
order to better understand the physiological relevance, we can examine the proliferation 
of naïve CD4+ T cells from OTII transgenic mice stimulated with serially diluted OVA 
peptide presented by antigen-presenting cells. In addition, we can investigate the in vivo 
proliferation of Jak3-deficient cells by adoptively transferring CFSE-labeled Jak3-/-OTII 
or Jak3+/-OTII T cells into congenic B6 recipients and priming the next day with OVA-
pulsed bone-marrow-derived DCs. No proliferative difference will be expected in Jak3+/- 
or Jak3-/- T cells. 
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CHAPTER III 
 Janus-Kinase-3-Dependent Signals Induce 
Chromatin Remodeling at the Ifng Locus during 
T Helper 1 Cell Differentiation 
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Introduction 
After antigen stimulation, naïve CD4+ T cells differentiate into one of several functional 
classes of effector cells; most frequent among these effector subsets are T helper (Th) 
type 1 (Th1) and Th type 2 (Th2) cells (188). The distinct patterns of cytokine production 
by activated Th1 and Th2 effector cells are the consequence of differential gene 
transcription, a process that is regulated at multiple steps (86, 189). The first step 
involves changes in chromatin accessibility. Subsequent to this, specific transcription 
factors access the open loci, where they bind to regulatory regions and activate gene 
transcription. Finally, binding of some transcription factors to their cis-acting regulatory 
elements directs chromatin-remodeling activity, leading to heritable changes in inducible 
transcriptional activity.   
 
The signaling pathways that contribute to Th differentiation have been well characterized 
(189, 190). When naïve CD4+ T cells are initially stimulated, latent transcription factors 
non-selectively stimulate low amounts of both IFN-γ and IL-4 production (55). In the 
presence of IL-12, Th1 differentiation is efficiently induced when IFN-γ stimulates Janus 
family tyrosine kinase (Jak) 1 and Jak2-dependent IFN-γR signaling, leading to the 
activation of signal transducer and activator of transcription 1 (STAT1), and thereby 
inducing expression of the Th1-specific transcription factor, T-bet (25). T-bet up-
regulates expression of IFN-γ, as well as the IL-12 receptor β2-subunit (IL-12Rβ2) (23, 
25). IL-12, acting via Jak2 and Tyk2 to activate STAT4, is not required for initial Th1 
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differentiation; instead, IL-12 amplifies the Th1 response by augmenting the production 
of IFN-γ (191). IL-12 signals together with T-bet also act to down-regulate the lineage 
commitment and cytokine expression of the alternative Th2 subset (23, 192). 
 
Epigenetic regulation of cytokine loci also play an essential role in Th differentiation 
(189). The first definite evidence of chromatin changes occurring during Th 
differentiation was reported by Rao and colleagues, who identified T cell lineage-specific 
DNAase I hypersensitive sites near the Ifng gene promoter and enhancer (81). These 
hypersensitive sites denote regions where chromatin structure has been altered, and they 
reflect the occupancy of these sequences with specific DNA binding proteins. Others 
have confirmed the importance of epigenetic changes in the regulation of Th1 and Th2 
cytokine gene transcription (1, 193). The chromatin modification most often studied 
during Th differentiation is histone acetylation (189). 
  
Changes in histone acetylation at the cytokine loci have been well documented during Th 
differentiation (55, 82, 85, 97). Interestingly, timecourse analysis indicates that the initial 
increase in histone acetylation at the regulatory regions of both the Il4 and Ifng genes is 
elicited in response to T cell receptor (TCR) signaling and is independent of the cytokine 
milieu (55).  However, in Th1- or Th2-polarizing conditions, cytokine locus-specific 
histone acetylation patterns are observed by day 5 post-activation, and are maintained in 
the differentiated effector cells (55, 82, 84).   
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STAT4, the transcription factor activated by IL-12 signaling, has been implicated in 
maintaining histone acetylation at the Ifng locus in Th1 cells (85). The Th1-specific 
transcription factor, T-bet, also promotes histone acetylation, as enforced expression of 
T-bet induces DNase I hypersensitivity and histone hyperacetylation at the Ifng locus in 
stimulated STAT4-deficient T cells (23, 82). However, the early events that contribute to 
Ifng locus epigenetic modification in Th1 cells are still not completely elucidated.  
 
The Jak1-STAT1 and Jak2-STAT4 signaling pathways are known to be important for Th 
differentiation. In contrast, a third Jak kinase, Jak3, has not previously been implicated in 
Th1 differentiation. Jak3 is required for signaling via the receptors for IL-2, IL-4, IL-7, 
IL-9, IL-15 and IL-21, all of which share a common receptor subunit, γc. These Jak3-
dependent cytokines primarily activate STAT5 and are critical for lymphoid generation, 
maturation, homeostasis and survival (194). While it is not surprising that Jak3 is 
essential for Th2 differentiation, due to its essential role in IL-4 signaling, little is known 
about the role of Jak3-dependent cytokine signals in Th1 differentiation. In this study we 
examined this issue by assessing Th1 differentiation and IFN-γ production by naïve CD4+ 
T cells from Jak3-deficient and STAT5-deficient mice. We complemented these studies 
with analysis of wild type CD4+ T cells treated with a pharmacological inhibitor of Jak3. 
Together, these experiments demonstrated that Jak3 and STAT5-dependent cytokine 
signals regulate Th1 differentiation by controlling chromatin remodeling at the Ifng locus. 
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Results 
IFN-γ production by Th1 cells is greatly reduced in the absence of Jak3 
To investigate the potential role of Jak3-dependent cytokine signals in Th1 
differentiation, we established an in vitro assay using homogenous populations of naïve 
Jak3-/- CD4+ T cells. To accomplish this, we first crossed Jak3-/- mice to the transgenic 
line expressing the OT-II TCR (195). Since γc cytokines are required for naïve CD4+ T 
cell survival in vivo (125), we also introduced a transgene expressing Bcl-2 (196). The 
resulting Jak3-/- OTII-transgenic Bcl2-transgenic (hereafter referred to as Jak3-/- OT-II 
Bcl2) mice have peripheral CD4+ T cells that predominantly exhibit a naïve (CD44lo) 
phenotype (Figure 3.1). However, to ensure a starting population of naïve cells, we chose 
to use CD4+CD8- single-positive (CD4 SP) thymocytes from these mice for our 
experiments.  
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Figure 3.1 CD4+ T cells in Jak3-/- OT-II Bcl2 mice are predominantly naïve.  
Splenocytes from the indicated mice were stained with antibodies to CD4, CD8 and 
CD44, and analyzed by flow cytometry.  
(a) Dot-plots show CD4 versus CD8 staining.  Numbers indicate the percentages of 
splenocytes in each quadrant. 
(b) Histograms show CD44 profiles on gated CD4+ cells. Numbers indicate the 
percentage of CD44hi cells in each CD4+ T cell population. 
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Figure 3.1 
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CD4 SP thymocytes were isolated from Jak3+/- or Jak3-/- OT-II Bcl2 mice, labeled with 
carboxyfluorescein diacetate succinimidyl ester (CFSE), stimulated with anti-CD3 and 
CD28 antibodies and cultured under non-skewing or Th1-skewing conditions without 
addition of exogenous IL-2. After four days, cells were restimulated, and IFN-γ was 
examined by intracellular cytokine staining. As shown in Figure 3.2a, in the absence of 
Jak3, the percentage of IFN-γ-producing cells was reduced from an average of 12.5±2.7% 
to 0.5±0.4% (P < 0.001) and 27.1±4.1% to 7.0±6.8% (P < 0.01) under non-skewing and 
Th1-skewing conditions, respectively. In addition, the percentage of lymphotoxin α-
producing cells was also decreased in the absence of Jak3 (data not shown). Cell division, 
as assessed by CFSE dilution, was similar between Jak3+/- and Jak3-/- OT-II Bcl2 cells (3-
2A), indicating that the reduced Th1 cytokine production in the Jak3-deficient T cells was 
not due to impaired proliferation. 
 
To confirm these findings, we examined cytokine secretion by Jak3-/- and Jak3+/- OT-II 
Bcl2 T cells following stimulation in Th1- and Th2-polarizing conditions. As shown in 
Figure 3.2b, under Th1-skewing conditions, Jak3-/- CD4 SP cells did not secrete Th2 
cytokines (IL-4, IL-5 and IL-10) and produced much less IFN-γ than Jak3+/- cells. As 
expected based on the role for IL-4 receptor signaling during Th2 differentiation (188), 
Jak3-/- CD4 SP cells stimulated under Th2-polarizing conditions did not produce 
detectable amounts of IL-4, IL-5 or IL-10 (Figure 3.2b).   
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To determine whether the impaired production of IFN-γ by Jak3-/- CD4 SP cells resulted 
from reduced expression of Ifng mRNA, we performed real-time quantitative RT-PCR. 
Consistent with the protein data, Ifng transcript expression was reduced in Jak3-/- CD4 SP 
cells compared to Jak3+/- cells, following culture under both non-skewing and Th1-
skewing conditions (Figure 3.2c). Together, these data indicate that Jak3-dependent 
signals are required for optimal production of IFN-γ in differentiated CD4+ T cells, and 
suggest that these signals promote maximal transcription of the Ifng gene.   
  
99
Figure 3.2 Differentiation of CD4+ T cells leads to impaired IFN-γ production in the 
absence of Jak3.  
CFSE-labeled CD4SP thymocytes from Jak3+/- and Jak3-/- OT-II Bcl2 mice were 
stimulated with anti-CD3 plus anti-CD28 and cultured under non-, Th1- or Th2-skewing 
conditions for 4 days. Non-skewing conditions have no exogenous cytokines added. Th1-
skewing conditions have IL-12 and anti-IL-4. Th2-skewing conditons have IL-4 and anti-
IFN-γ.  
(a) Cells were restimulated with PMA plus ionomycin for 5 hours. Dot-plots show 
intracellular staining for IFN-γ versus CFSE fluorescence. The graphs show percentages 
of IFN-γ producing cells from five different experiments, with the means indicated by 
horizontal bars. Differences between Jak3+/- and Jak3-/- responses are statistically 
significant, with the p values indicated.  
(b, c) Following 4-day culture in Th1- or Th2-polarizing conditions, cells were 
restimulated with PMA and ionomycin for 24h. b) Supernatants were analyzed for 
production of IFN-γ, IL-4, IL-5 and IL-10 by ELISA. Error bars indicate the standard 
deviation (SD) of values obtained from stimulations performed in triplicate. c) Ifng 
mRNA expression was analyzed by real-time quantitative PCR. Data are normalized to 
amounts of 18srRNA in each sample. Error bars indicate the SD of transcript values 
obtained from triplicate reactions. 
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Figure 3.2 
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Transcription factors important for Th1 differentiation are independent of Jak3 
Our previous studies indicated that T cells from Jak3-deficient mice have intact TCR 
signaling (197). To examine whether IFN-γ-STAT1 and IL-12-STAT4 pathways are 
intact in the absence of Jak3, freshly-isolated CD4 SP thymocytes from Jak3+/- and Jak3-/- 
OT-II Bcl2 mice were stimulated with IFN-γ, and assessed for STAT1 tyrosine 
phosphorylation (Figure 3.3a); further, differentiated Jak3+/- and Jak3-/- Th1 cells were 
assessed for STAT4 phosphorylation in response to IL-12 stimulation (Figure 3.3b). As 
shown, both of these responses were intact in the absence of Jak3. We also examined up-
regulation of T-bet, a master transcription factor for Th1 differentiation which is induced 
by IFN-γ signaling in T cells (23, 27). While no T-bet was detected in naïve T cells, 
Jak3+/- CD4 SP cells up-regulated T-bet mRNA and protein after stimulation in both non-
skewing and Th1-polarizing conditions (Figure 3.3c and data not shown). Jak3-/- cells 
failed to induce T-bet under non-skewing conditions, perhaps as a result of their failure to 
produce any IFN-γ following activation. In contrast, Jak3-/- cells cultured under Th1-
skewing conditions expressed comparable amounts of T-bet mRNA and protein 
compared to the Jak3+/- control cells (Figure 3.3c). Together with our previous studies, 
these data indicate that three important pathways for Th1 differentiation, TCR signaling, 
IFN-γ-STAT1, and IL-12-STAT4, are intact in the absence of Jak3-dependent cytokine 
signals. 
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Figure 3.3 STAT1 phosphorylation, STAT4 phosphorylation and T-bet expression 
are not impaired in Jak3-deficient Th1 cells.  
(a) Freshly-isolated purified CD4SP thymocytes from Jak3+/- and Jak3-/- OT-II Bcl2 mice 
were stimulated with or without IFN-γ (100 ng/ml) for 30 min. Total cell lysates were 
prepared and blotted for STAT1p and total STAT1. CD4+ splenocytes from Jak3+/+ OTII-
transgenic mice were used as a control.  
(b) Purified CD4SP thymocytes from Jak3+/- and Jak3-/- OT-II Bcl2 mice were cultured in 
Th1-skewing conditions for 4 days. Cells were rested overnight, and then stimulated with 
or without IL-12 (15 ng/ml) for 25 min. Total cell lysates were prepared and blotted for 
STAT4p and total STAT4.  
(c) Purified CD4SP thymocytes from Jak3+/- and Jak3-/- OT-II Bcl2 mice were stimulated 
under non-, Th1- or Th2-skewing conditions for 4 days. T-bet mRNA amounts were 
analyzed by real-time quantitative PCR. Data are normalized to the levels of 18srRNA in 
each sample (left panel). Total cell lysates from freshly isolated CD4SP thymocytes 
(naïve) or Th1-polarized cells (Th1) were prepared and immunoblotted for T-bet and β-
actin (right panel). Error bars indicate the SD of transcript values obtained from triplicate 
reactions. 
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Figure 3.3 
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Pharmacological inhibition of Jak3 leads to impaired IFN-γ production during Th1 
differentiation 
To rule out the possibility that Jak3-/- T cells are developmentally abnormal, leading to 
their impaired Th1 differentiation, we examined cytokine production by Jak3+/+ CD4+ T 
cells treated with a pharmacological Jak3 inhibitor. To determine the optimal 
concentration of PS078507 for Jak3 inhibition in murine peripheral CD4+ T cells, we 
assessed IL-2-induced STAT5 phosphorylation after treatment with varying 
concentrations of PS078507 (Figure 3.4a). PS078507 completely inhibited IL-2-induced 
STAT5 phosphorylation in Jak3+/+ CD4+ T cells at 625nM. We also found that PS078507 
had no effect on T cell proliferation induced by TCR stimulation over the course of a 4-
day assay (Figure 3.5a). Furthermore, PS078507 had no inhibitory effect on TCR 
signaling, as assessed by CD69 up-regulation following TCR stimulation of naïve Jak3+/+ 
CD4+ T cells (Figure 3.4b).   
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Figure 3.4 Characterization of the Jak3 inhibitor, PS078507. 
(a) Purified CD4+ splenocytes from Jak3+/+ mice were stimulated with anti-CD3 plus 
anti-CD28 for 2 days, rested for 4 hours, incubated with vehicle alone or serial-diluted 
PS078507 for 15 minutes, then stimulated with medium (first lane) or IL-2 (50 ng/ml, all 
other lanes) for 15 minutes.  Cell lysates were prepared and immunoblotted for STAT5p 
and β-actin.  
(b) CD4+ T cells were purified from Jak3+/+ OTII-transgenic mice and stimulated with 
anti-CD3 plus anti-CD28 in the presence of vehicle alone, or the Jak3 inhibitor PS078507 
at 312 nM or 625 nM.  After 6 hours, cells were harvested and stained with anti-CD69 
antibodies and analyzed by flow cytometry.  Histograms show CD69 expression on 
unstimulated cells, and cells stimulated under the indicated conditions. 
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Figure 3.4 
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We then tested PS078507 for its effect on Th1 differentiation leading to IFN-γ 
production. As shown in Figure 3.5b and 3.5c, inhibition of Jak3 enzymatic activity in 
Jak3+/+ OT-II transgenic CD4+ T cells greatly diminished the percentage of IFN-γ 
secreting cells from an average of 19.7±7.3% to 1.9±1.3% (P < 0.01) under non-skewing 
conditions, and 42.7±8.9% to 19.5±7.0% (P < 0.01) under Th1-skewing conditions. As 
seen with Jak3-/- T cells, T-bet expression was greatly reduced in CD4+ T cells cultured 
under non-skewing conditions in the presence of PS078507; however Jak3+/+ T cells 
stimulated under Th1-polarizing conditions showed normal up-regulation of T-bet, even 
in the presence of the Jak3 inhibitor (Figure 3.5d). These findings confirmed the results 
seen with Jak3-/- CD4 SP cells. Together, these data indicate that the impaired production 
of IFN-γ in Th1 cells differentiating in the absence of Jak3-dependent signals cannot be 
explained by defects in the known transcription factors required for Ifng gene expression.   
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Figure 3.5 Pharmacological inhibition of Jak3 during Th1 differentiation leads to 
impaired IFN-γ production.  
(a) Purified CD4+ splenocytes from Jak3+/+ OTII-transgenic mice were labeled with 
CFSE and stimulated with anti-CD3 plus anti-CD28 for 4 days in the presence of vehicle 
alone (WT vehicle) or PS078507 at 625 nM (Jak3 inhibitor). Histograms show CFSE 
fluorescence.  
(b, c, d) CD4+ splenocytes from Jak3+/+ OTII-transgenic mice were cultured under non- 
and Th1-skewing conditions for 4 days, in vehicle alone or PS078507 (625 nM). Cells 
were restimulated with PMA plus ionomycin for 6 hours. b) Dot-plots show IFN-γ 
intracellular staining versus forward scatter. c) The graphs show percentages of IFN-γ 
producing cells from four different experiments, with the means indicated by horizontal 
bars. Differences between cells cultured in vehicle alone or PS078507 (Jak3 inhibitor) are 
statistically significant, with the p values indicated. d) Total cell lysates were prepared 
and immunoblotted for T-bet and β-actin.  
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Figure 3.5 
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In vivo binding of T-bet to the Ifng promoter is impaired in the absence of Jak3 
signals 
The Ifng gene is a direct target of the transcription factor, T-bet (31). Since T-bet protein 
expression was not reduced in the absence of Jak3-dependent signals, we considered the 
possibility that Jak3-dependent signaling might regulate the ability of T-bet to interact 
with its responsive element in the Ifng promoter. To address this, chromatin 
immunoprecipitation (ChIP) assays were performed to assess the in vivo binding of T-bet 
to the Ifng proximal promoter in Jak3+/- versus Jak3-/- OT-II Bcl2 cells (Figure 3.6; 
primer set #1). CD4 SP thymocytes were activated and cultured under Th1-skewing 
conditions for 4 days. As shown in Figure 3.7a, naive CD4 SP thymocytes from Jak3+/- or 
Jak3-/- OT-II Bcl2 mice had no detectable T-bet bound to the Ifng promoter (lane 3 and 
lane 6). Following Th1 differentiation, T-bet bound to the Ifng promoter was easily 
detectable in Jak3+/- T cells, but substantially diminished in Jak3-/- T cells (lane 9 and 
lane 12). We confirmed these findings with Jak3+/+ CD4+ T cells stimulated in Th1-
skewing conditions in the presence of the Jak3 inhibitor PS078507 (Figure 3.7b). Overall 
these data correlated with the pattern of IFN-γ production by Jak3-/- T cells, or following 
Jak3 inhibition, suggesting that reduced production of IFN-γ under these conditions may 
result from an impaired ability of T-bet to bind to the Ifng promoter, and thereby to 
activate Ifng gene transcription.  
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Figure 3.6 Schematic of the Ifng regulatory regions. 
The positions of PCR primers for ChIP experiments and accessibility assay are labeled, 
and indicated on a map of the murine Ifng locus.  
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Figure 3.6 
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Figure 3.7 In vivo binding of T-bet to the Ifng promoter is impaired in Jak3-
deficient cells.  
(a) Purified CD4SP thymocytes from Jak3+/- and Jak3-/- OT-II Bcl2 mice were cultured 
under Th1-skewing conditions for 4 days (lanes 7-12) and compared with freshly isolated 
cells (naïve, lanes 1-6). ChIP analysis was done with an anti-T-bet (lanes 3, 6, 9, 12) or a 
rabbit IgG control antibody (lanes 2, 5, 8, 11).  
(b) CD4+ splenocytes from Jak3+/+ OTII-transgenic mice were cultured with vehicle 
alone or PS078507 (625nM) under Th1-skewing conditions for 4 days. ChIP analysis was 
done with a rabbit IgG antibody control (top) or an anti-T-bet (middle). The location of 
PCR primers is indicated in Figure 3.6.  
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Figure 3.7 
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The apparent inability of T-bet to promote transcription of the Ifng gene is not due to a 
global defect in T-bet activity or function. Jak3+/- and Jak3-/- OT-II Bcl2 CD4 SP 
thymocytes were activated and stimulated under Th1-polarizing conditions for 4 days, 
and mRNA expression of the IL-12Rβ2 chain, Hlx, and Ets-1 genes was examined 
(Figure 3.8).  Both populations showed comparable expression of transcripts encoding 
the IL-12Rβ2 chain and Ets-1, whereas Jak3-/- cells had reduced expression of Hlx 
mRNA.  As IL-12Rβ2 and Hlx are both transcriptional targets of T-bet (23, 26), these 
findings indicate that T-bet is transcriptionally competent to promote expression of IL-
12Rβ2, but selectively loses the ability to mediate transcription of other genes, such as 
Ifng and Hlx.  
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Figure 3.8 IL-12Rβ2, Hlx and Ets-1 mRNA levels Th1 cells from Jak3+/- and Jak3-/- 
OT-II Bcl-2 mice.  
CD4SP thymocytes from Jak3+/- and Jak3-/- OT-II Bcl2 mice were left unstimulated 
(naïve) or were stimulated under Th1-skewing conditions for 4 days (Th1-skewing).  IL-
12Rβ2 mRNA (a), Hlx mRNA (b) and Ets-1 mRNA (c) amounts were analyzed by real-
time quantitative PCR.  Data are normalized to the amounts of 18SrRNA in each sample. 
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Figure 3.8 
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Th1 cells differentiating in the absence of Jak3 signaling show reduced Ifng 
promoter accessibility 
The results described above suggested that T-bet function in Th1 cells may be regulated 
by chromatin structure. To examine this issue further, we examined the accessibility of 
the Ifng proximal promoter using restriction endonuclease digestion followed by ligation-
mediated polymerase chain reaction (LM-PCR; Figure 3.6, primer set #2). As shown in 
Figure 3.9a, the Ifng promoter in naïve Jak3+/- or Jak3-/- CD4 SP thymocytes was not 
accessible to endonuclease digestion. Following four days of stimulation under Th1-
polarizing conditions, the Ifng promoter showed dramatically increased accessibility in 
Jak3+/- SP cells. In contrast, the signal from the Jak3-/- SP cells was reduced to ~30% of 
that seen in the control cells, indicating that the Ifng promoter is markedly less accessible 
in Jak3-deficient T cells cultured under Th1-skewing conditions. 
 
Using the ChIP assay, we next examined the acetylation status of histone H3 at the Ifng 
promoter in Th1 cells stimulated in the presence or absence of functional Jak3 (Figure 3.6, 
primer set 3). As shown in Figure 3.9b, naïve Jak3+/- and Jak3-/- OT-II Bcl2 CD4 SP 
thymocytes had a low level of histone H3 acetylation at the Ifng promoter. Following 
four days of culture in Th1-skewing conditions Jak3+/- cells displayed strong 
hyperacetylation of histone H3 at the Ifng promoter. In contrast, histone H3 acetylation of 
the Ifng promoter was 3-fold reduction in Jak3-/- Th1 cells, consistent with the diminished 
accessibility of this region to restriction endonuclease digestion. These findings were also 
confirmed with Jak3+/+ T cells stimulated under Th1-polarizing conditions in the 
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presence of the Jak3 inhibitor, PS078507 (Figure 3.9c). Furthermore, all findings were 
confirmed with a second set of PCR primers (Figure 3.6, primer set #4; data not shown). 
Together, these data strongly suggest that Jak3-dependent cytokine signals are required 
for chromatin remodeling of the Ifng locus during Th1 differentiation.  
 
To further assess the role of histone acetylation in Jak3-dependent IFN-γ production, we 
pharmacologically-induced histone acetylation of the Ifng promoter using a histone 
deacetylase (HDAC) inhibitor, sodium butyrate. Addition of sodium butyrate during Th1 
differentiation of both Jak3+/- and Jak3-/- OT-II Bcl2 CD4 SP thymocytes resulted in 
increased production of IFN-γ compared to untreated cells (Figure 3.9d). This finding 
was confirmed with Jak3+/+ CD4+ T cells stimulated in the presence of the Jak3 inhibitor, 
PS078507 (data not shown). Overall, the data presented here indicate that Jak3-dependent 
cytokine signals induce IFN-γ production via chromatin remodeling of the Ifng locus.  
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Figure 3.9 Chromatin accessibility of the Ifng promoter is reduced in Th1 cells 
differentiated in the absence of Jak3-dependent signals.  
(a, b) Purified CD4SP thymocytes from Jak3+/- and Jak3-/- OT-II Bcl2 mice were 
stimulated under Th1-skewing conditions for 4 days (lanes 7-12). Freshly-isolated cells 
(naïve, lanes 1-6) were used for comparison. a) Nuclei were isolated, digested with HinfI, 
and three-fold dilutions of genomic DNA were subjected to LM-PCR with primers for 
the Ifng proximal promoter (LM-PCR primer set #2). b) ChIP analysis was performed 
with an antibody to acetylated histone H3 (lanes 3, 6, 9, 12) or a rabbit IgG control 
antibody (lanes 2, 5, 8, 11) (H3 primer set #3).  
(c) CD4+ splenocytes from Jak3+/+ OTII-transgenic mice were cultured in vehicle alone 
or with the Jak3 inhibitor (625nM) in Th1-skewing conditions for 4 days. ChIP analysis 
was performed with a rabbit IgG control antibody (top) or antibody to acetylated histone 
H3 (middle) (H3 primer set #3).  
(d) Purified CD4SP thymocytes from Jak3+/- and Jak3-/- OT-II Bcl2 mice were stimulated 
under Th1-skewing conditions. Parallel cultures were treated with or without sodium 
butyrate (SB; 200μM), added at 24h post-stimulation. At day 4, cells were restimulated 
with PMA and Ionomycin. The graph shows the percentage of cells producing IFN-γ as 
assessed by intracellular staining. Data are pooled from three independent experiments.  
Differences between sodium butyrate treated and untreated samples for each genotype of 
cells are statistically significant, with p values indicated. Differences between sodium 
butyrate treated Jak3+/- and Jak3-/- cells are not significant. Error bars indicate the SD of 
percent of IFN-γ-producing cells obtained from three independent experiments.
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Figure 3.9 
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Jak3 acts at 24-72 hours following activation to promote histone acetylation at the 
Ifng promoter  
Our data indicate that Jak3-dependent signals promote IFN-γ production by inducing 
histone H3 acetylation. Examining the timecourse of histone H3 acetylation at the Ifng 
promoter during Th1 differentiation by ChIP assay demonstrated only a low basal amount 
of histone H3 acetylation in the first 24h post-stimulation. Histone H3 acetylation 
increased at 48h and then increased further at 72h (Figure 3.10a). These data indicate that 
during Th1 differentiation, selective Ifng chromatin remodeling occurs rapidly between 
24-72h following activation.  
 
Use of a small molecule Jak3 inhibitor allowed us to assess the kinetic parameters of the 
Jak3-dependent signal, and to correlate these data to the changes in histone acetylation. 
For these experiments, Jak3+/+ CD4+ T cells were stimulated under Th1-polarizing 
conditions in the absence of inhibitor PS078507, or with inhibitor added at varying times 
following the initial activation of the T cells. At day 4, cells were restimulated and IFN-γ 
production was examined by intracellular cytokine staining. Consistent with the histone 
H3 acetylation pattern, PS078507 inhibited IFN-γ production when cells were treated 
with the inhibitor starting at 0h, 1h, 3h, 6h, 12h and 24h post-stimulation. However, the 
inhibitory effect of PS078507 was substantially diminished when inhibitor was applied at 
48h, and was ineffective when added at 72h post-stimulation (Figure 3.10b). Similarly, 
acetylation of histone H3 at the Ifng promoter was completely inhibited by PS078507 
when added 24h after initial T cell activation, but was ineffective when cells were 
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stimulated under Th1-polarizing conditions for 72h prior to addition of the Jak3 inhibitor 
(Figure 3.10c). These findings indicate that the predominant action of Jak3-dependent 
signals in promoting optimal IFN-γ production occurs between 24-72h after stimulation, 
and that these signals regulate Ifng chromatin remodeling during Th1 differentiation.  
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Figure 3.10 The Jak3-dependent signals are required at 24-72h of stimulation to 
induce histone acetylation at the Ifng locus.  
(a) CD4+ splenocytes were isolated from Jak3+/+ OTII-transgenic mice and were 
stimulated under Th1-skewing conditions for 0h, 12h, 24h, 48h and 72h. At each 
timepoint, ChIP analysis was performed with a rabbit IgG control antibody (top) or an 
antibody to acetylated histone H3 (H3 primer set #3).  
(b) CD4+ splenocytes from Jak3+/+ OTII-transgenic mice were stimulated under Th1-
skewing conditions, with vehicle alone or the Jak3 inhbitor (PS078507 at 625nM) added 
at the indicated timepoints following the initiation of the cultures. All cultures were 
harvested at day 4, at which time the cells were restimulated and analyzed for IFN-γ 
production by intracellular cytokine staining. Cell initially cultured in vehicle alone were 
restimulated in the presence of PS078507 at 625nM (Restim).  
(c) CD4+ splenocytes from Jak3+/+ OTII-transgenic mice were stimulated under Th1-
skewing conditions in vehicle alone or with PS078507 (625nM) added at the indicated 
times following the initiation of the cultures. At day 4, ChIP analysis was performed with 
a rabbit IgG control antibody (top) or an antibody to acetylated histone H3 (middle) (H3 
primer set #3). Freshly isolated Jak3+/+ OTII-transgenic cells were used for comparison 
(naïve). 
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Figure 3.10 
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STAT5 and IL-2 promote optimal IFN-γ production during Th1 differentiation 
Following Jak kinase activation, STAT5 translocates to the nucleus where it activates the 
transcription of target genes (198). In human NK cells, a STAT5 binding site has been 
identified in a distal region of the IFNG gene, 3.6kb upstream of the transcriptional start 
site. This STAT5 binding site serves as a target for epigenetic modification of the IFNG 
locus, or as an IL-2-induced transcriptional enhancer (199, 200). STAT5 also binds to 
this region of the IFNG gene in human T cells, where it enhances IFNG gene expression 
following CD2 stimulation (200). In murine T cells, STAT5 binding to the Ifng promoter 
has not previously been examined. However, several Ifng regulatory elements have been 
identified in these cells through DNase I hypersensitive site (HS) mapping and conserved 
noncoding sequence (CNS) searching. These elements are IfngCNS-34 (91), IfngCNS-22 
(91), IfngCNS-5.5 (90, 95), HS-0.3 (81) and IfngCNS+18 (90), which are -34kb, -22kb, -
5.5kb, -0.3kb and +18kb from the IFN-γ transcriptional initiation site, respectively. To 
investigate whether STAT5 binds to any of these regulatory sites, we utilized the ChIP 
assay (Figure 3.6, primer sets #5-10). As shown in Figure 3.11a, no STAT5 binding was 
detected to IfngCNS-34 or IfngCNS-22 (Figure 3.11a, lanes 1 and 2). Furthermore, 
although STAT5 binds to the -3.6kb region of the human IFNG gene, we could not detect 
STAT5 binding to the corresponding region of the murine Ifng locus (Figure 3.11a, lane 
4). Interestingly, CD4+ T cells cultured in Th1-polarizing conditions for 48hr exhibited 
easily detectable STAT5 binding to IfngCNS-5.5 and HS-0.3 following IL-2 stimulation 
(Figure 3.11a, lanes 3 and 5). In addition, we found extremely weak binding of STAT5 to 
  
127
IfngCNS+18 (Figure 3.11a, lane 6). These data suggest that the Jak3-STAT5 pathway 
might directly regulate Ifng gene expression. 
 
To determine whether STAT5 is required during Th1 differentiation for optimal IFN-γ 
production, we utilized T cells from conditional STAT5a and STAT5b double-deficient 
mice (201). To accomplish this, mice carrying a floxed Stat5 allele were crossed to CD2-
Cre transgenic mice (202). CD4 SP thymocytes were isolated and stimulated under Th1-
polarizing conditions. After four days, cells were restimulated and IFN-γ production was 
assessed by intracellular cytokine staining. Consistent with the data from CD4 SP cells 
lacking Jak3, STAT5-deficient cells also showed impaired differentiation of IFN-γ-
producing Th1 effector cells (Figure 3.11b). Furthermore, addition of sodium butyrate 
during the differentiation process promoted greatly enhanced production of IFN-γ in T 
cells lacking STAT5 (Figure 3.11b). 
 
 To determine if IL-2 is the cytokine responsible for activating Jak3 and STAT5 during 
Th1 differentiation and thereby promoting IFN-γ production, we stimulated wild-type 
(Jak3+/+ Stat5ab+/+) T cells under Th1-polarizing conditions in the presence of anti-IL-2 
and anti-IL2 receptor blocking antibodies. As shown in Figure 3.11c, inhibition of IL-2 
signaling was nearly as effective at preventing the differentiation of IFN-γ-producing Th1 
cells as was the Jak3 inhibitor, PS078507. We also tested whether addition of exogenous 
IL-7 could replace IL-2 and promote optimal IFN-γ production. As shown in Figure 
3.11c, IL-7 was only modestly effective at promoting IFN-γ production. The relative 
  
128
activities of IL-2 and IL-7 at inducing IFN-γ production during Th1 differentiation 
correlated well with their ability to induce STAT5 tyrosine phosphorylation in 
differentiating Th1 cells (Figure 3.11d). These data provide further evidence consistent 
with a role for STAT5 in promoting IFN-γ production during Th1 differentiation.  
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Figure 3.11 STAT5 and IL-2 are required for optimal IFN-γ production during Th1 
differentiation.  
(a) Purified CD4+ T cells from Jak3+/+ OTII-transgenic mice were stimulated and 
cultured in Th1-skewing conditions for 2 days. Cells were rested overnight, and then 
restimulated with IL-2 (50 ng/ml) for 1h. ChIP analysis was performed using an STAT5a 
antibody.  Rabbit IgG antibody was used as a negative control.  Primers for each of the 
indicated Ifng regulatory regions were designed to detect STAT5 binding (STAT5 primer 
sets #5-10).  
(b) Purified CD4SP thymocytes from CD2-Cre transgenic Stat5fl/+ and Stat5fl/fl mice were 
stimulated under Th1-skewing conditions. Sodium butyrate (200 μM) was added at 24h 
post-stimulation. At day 4, cells were restimulated with PMA and Ionomycin. Bar graphs 
indicate the percentages of IFN-γ producing cells. Data are representative of two 
independent experiments with similar results.  
(c) CD4+ splenocytes from Jak3+/+ mice were cultured under Th1-skewing conditions for 
4 days, in the indicated conditions. Jak3 inhibitor PS078507 was used at 625nM, IL-2 
blocking included anti-IL-2 (10 μg/ml), anti-CD25 (10 μg/ml) and anti-CD122 (10 
μg/ml), recombinant IL-7 (rIL-7, 10 ng/ml) was added together with IL-2 blocking 
antibodies. Cells were restimulated with PMA plus ionomycin for 6 hours. Histograms 
show IFN-γ intracellular staining.  
(d) Purified CD4+ splenocytes from Jak3+/+ mice were stimulated with anti-CD3 plus 
anti-CD28 for 24h, rested for 4 hours, then stimulated with medium (first lane), IL-2 or 
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IL-7, at 50 ng/ml or 100 ng/ml for 15 minutes. Cell lysates were prepared and 
immunoblotted for STAT5p andtotal STAT5. 
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Figure 3.11 
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Discussion 
Th1 versus Th2 cell fate determination and maintenance are regulated by exogenous 
signals through the TCR and cytokine receptors, which together activate distinct 
transcription factor networks and promote epigenetic modifications of lineage-specific 
cytokine loci (86). Here we show that CD4+ T cells require Jak3-dependent signals to 
produce optimal amounts of IFN-γ during Th1 differentiation, independently of effects on 
cell division. Jak3 activity is not required for TCR signaling, nor for the IFN-γ-STAT1-T-
bet and IL-12-STAT4 pathways. Instead, Jak3-dependent signals regulate chromatin 
remodeling at the Ifng locus, promote histone H3 acetylation, and control the accessibility 
of T-bet to the Ifng promoter to induce optimal IFN-γ production by Th1 cells.   
 
Helper T cell differentiation is coupled to cell cycle progression. As seen first by Bird 
and colleagues, IFN-γ is expressed by an increasing frequency of cells with each cell 
division (1), a finding also illustrated in our data (Figure 3.2a). Although γc-dependent 
cytokines have been shown to promote lymphoid proliferation (146), we find that cells 
lacking Jak3 (i.e., Jak3-/-) as well as Jak3+/+ cells treated with a small molecule Jak3 
inhibitor, are able to proliferate comparably to wild type cells in the context of a 4-day in 
vitro assay. Thus we conclude that Jak3-dependent signals are directly influencing 
effector T cell differentiation, rather than proliferation.   
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Our data indicate that a third cytokine signal, mediated by Jak3 and STAT5, is required 
during the early stages of Th1 differentiation (prior to 72h).  We complemented our 
studies on Jak3-deficient and STAT5-deficient T cells with experiments on wild type 
CD4+ T cells treated with a small molecule inhibitor of Jak3 enzymatic activity, 
PS078507. In all cases, the inhibitor data are completely concordant with the results 
obtained using Jak3-/- cells, demonstrating that the effects seen are not due to abnormal 
development of, or compensatory changes in Jak3-/- or Stat5ab-/- cells. Further, the 
experiments utilizing the Jak3 inhibitor indicate that Jak3 kinase activity is required for 
its role in promoting Ifng chromatin remodeling.  
 
One potential caveat of the inhibitor experiments is the fact that PS078507 has significant 
inhibitory activity on Jak1, as well as Jak3. Since Jak1 is a key component of IFN-γ 
receptor signaling (203), and IFN-γ  receptor signaling has been implicated in the 
induction of T-bet expression and thus in Th1 differentiation (25), inhibition of Jak1 
activity by PS078507 could contribute to the impaired Th1 differentiation seen in the 
presence of the inhibitor. However, several lines of evidence indicate that this scenario is 
unlikely. First, we detect normal amounts of T-bet in wild-type CD4+ T cells cultured 
under Th1-polarizing conditions in the presence of PS078507. Second, we observe that 
IFN-γ  receptor is totally absent from CD4+ T cells by six hours after initial activation, 
and further, that IFN-γ-induced STAT1 phosphorylation is also undetectable by three 
hours after T cell activation (204, 205) (Figure 3.12). Because we find that PS078507 still 
inhibits optimal IFN-γ production when added to Th1-polarizing cultures after 24 hours 
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of activation, it is extremely unlikely that its ability to block this response is due to 
inhibition of IFN-γ receptor signaling. Thus, the concordance between our findings based 
on analysis of Jak3-/- T cells with the data using PS078507 provide strong support for a 
role of Jak3 signaling in Th1 differentiation. 
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Figure 3.12 IFN-γR β2 and STAT1 phosphorylation are down-regualted in the early 
stages of Th1 differentiation.  
CD4+ T cells were purified from Jak3+/+ OTII-transgenic mice and stimulated under Th1-
skewing conditions. 
(a) Following 6h and 24h stimulation, activated T cells were harvested, total cell lysates 
were prepared and blotted for IFN-γR β2 and β-actin. Naïve CD4+ T cells were used as a 
control.  
(b) Naïve CD4+ T cells and 24h-stimulated Th1cells were stimulated with or without 
IFN-γ (100 ng/ml) for 30 min. Total cell lysates were prepared and blotted for STAT1p 
and β-actin.  
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T-bet is considered the master regulator of Th1 lineage commitment (27). T-bet controls 
Th1 programs by promoting Ifng gene remodeling (23); in addition, T-bet acts to directly 
induce transcription of the Ifng (31), IL-12Rβ2 (23), and Hlx (26) genes. With regard to 
Ifng expression, both of these functions require T-bet binding to the Ifng locus. 
Interestingly, our data indicate that T-bet protein expression alone is not sufficient for 
maximal T-bet binding to the Ifng promoter. These findings could be accounted for by 
two possible mechanisms.  First, it is formally possible that a potential post-translational 
modification of T-bet (206) is impaired in the absence of Jak3-dependent signals. 
Arguing against this possibility, the expression of the IL-12Rβ2 chain, one of the direct 
transcriptional targets of T-bet (23), is not impaired in Th1 cells lacking Jak3, indicating 
that the T-bet protein present in these cells is transcriptionally active.  
 
Instead, we favor the notion that impaired T-bet binding in vivo to the Ifng gene is due to 
reduced accessibility of the Ifng locus in the absence of Jak3-dependent signals. In 
previous studies, the importance of T-bet and STAT4 in Ifng chromatin remodeling was 
demonstrated using T-bet- or STAT4-deficient T cells, or by a retroviral over-expression 
system (23, 82, 85); therefore it was not possible to determine precisely when these 
factors carry out their functions. By using a pharmacological Jak3 inhibitor we find that 
Jak3-dependent signals function at 24-72h following initial T cell activation. Since TCR 
signals act within 24h to regulate Ifng epigenetic modification (55), these data suggest 
that Jak3-dependent signals function after TCR signaling to promote chromatin 
remodeling. The impaired ability of T-bet to bind to the Ifng promoter in Jak3-/- cells 
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further suggests that Jak3-dependent signals act prior to, or synergistically with T-bet, to 
regulate Ifng gene expression. After 72h, this Jak3-dependent signal is dispensable, and 
T-bet plus STAT4 are sufficient to reinforce and maintain the open status of the Ifng 
gene. 
 
Chromatin remodeling at the Ifng locus may occur by STAT5 recruitment of histone 
acetyltransferases or chromatin remodeling factors, as has been described in other 
systems (122, 136, 142-144). While we have been unable to detect constitutive STAT5 
binding to the Ifng locus in differentiating Th1 cells, IL-2 stimulation of T cells 48h after 
initial activation induces robust binding of STAT5 to Ifng regulatory regions, including 
IfngCNS-5.5 and HS-0.3. Interestingly, T-bet is also able to bind to these regions (90, 
95). As our data indicate that T-bet binding to the Ifng proximal promoter is greatly 
reduced in the absence of STAT5 activation, we propose that STAT5 functions either 
before, or synergistically with T-bet, to regulate the chromatin remodeling process.  
 
Early studies provided evidence that IL-2 ‘primes’ T cells for production of both IFN-γ 
and IL-4 (207). More recently, IL-2 receptor signaling via STAT5 has been implicated in 
the regulation of IL-4 expression and Th2 differentiation, independently of the IL-
4/STAT6 pathway (73, 74). These data, together with our findings, suggest the intriguing 
possibility that IL-2, or another γc-dependent cytokine, may be required in the initial 
stages of both Th1 and Th2 differentiation for chromatin remodeling at the Ifng and Il4 
locus, respectively. This requirement would thereby couple effector CD4+ T cell 
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differentiation with appropriate survival and growth-promoting signals. In our in vitro 
system, IL-2 is the cytokine activating Jak3 and promoting IFN-γ production during Th1 
differentiation. It remains to be determined whether STAT5 is inducing chromatin 
remodeling at the Il4 locus during Th2 differentiation. Nonetheless, these data 
demonstrate that optimal effector CD4+ T cell differentiation depends on an additional 
cytokine signal that is not lineage-specific, but is required for epigenetic regulation of 
lineage-specific cytokine loci. 
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CHAPTER IV 
 Discussion 
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A synopsis 
The cell-mediated immune response is essential for the immune system to defend against 
numerous pathogens. Understanding the cellular and molecular regulation of T cell 
immunity is the basis for developing new drugs that control disease processes. The data 
presented in this thesis have clearly demonstrated an important role for a group of 
cytokines, which share the γc chain of their receptors, in the generation and maintenance 
of T cell effector function.   
 
Whether γc cytokines are essential for T cell proliferation is under debate. In chapter two, 
I examined the role of γc cytokines during naïve CD4+ T cell proliferation in vitro. By 
inactivating Jak3, the downstream master kinase of γc cytokines, we find that γc 
cytokines are not required for naïve CD4+ T cell proliferation in vitro; rather, they are 
important for preventing cell death after activation. TCR and CD28 stimulation provides 
sufficient signals to promote cell cycle progression by up-regulating cyclin D, cyclin E 
and cyclin A and down-regulating the cell cycle inhibitor, p27kip1. Our data clearly 
demonstrate that after activation, γc cytokines serve as a survival factor rather than a 
proliferative factor for CD4+ T cells.   
 
In chapter three, I investigated the function of γc cytokines in naïve CD4+ T cell 
differentiation. We report that in the absence of Jak3-dependent signals, naïve CD4+ T 
cells proliferate robustly, but produce little IFN-γ after Th1 polarization in vitro.  We find 
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that the defect in IFN-γ production is not due to reduced STAT1 activation in response to 
IFN-γ signaling, nor is it due to reduced STAT4 activation in response to IL-12.  Further, 
following activation in Th1-skewing conditions, naïve Jak3-deficient CD4+ T cells up-
regulate T-bet to a level comparable with wild-type T cells. A chromatin 
immunoprecipitation assay reveals, instead, that T-bet binding to the Ifng promoter is 
greatly diminished in the absence of Jak3-dependent signals, and that reduced T-bet 
binding correlates with a decrease in promoter accessibility and histone acetylation at the 
Ifng gene locus.  We also show that Jak3-dependent signals function at 24-72h following 
initial T cell activation to promote histone acetylation at the Ifng promoter.  To our 
knowledge, these data provide the first evidence for a critical role of Jak3-dependent 
cytokine signals in Th1 differentiation, and indicate that Jak3 regulates epigenetic 
modification and chromatin remodeling of the Ifng locus during Th1 differentiation. 
 
Overall, my thesis extends the general knowledge of the role of γc cytokines in the 
maintenance and function of the immune system. Specifically, we demonstrate that while 
γc cytokines are not required for T cell proliferation, they are critical for the 
differentiation and survival of effector T cells. We have discovered a novel signaling 
pathway for γc cytokines in regulating chromatin remodeling at the Ifng locus during Th1 
differentiation.  
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The following sections attempt to reconcile the role of γc cytokines in the effector 
functions of T cells and propose several models based on our data and the exiting 
literature. 
 
Proliferation versus differentiation of naïve CD4+ T cells 
Naïve CD4+ T cells are activated through the ligation of their TCR and engagement of 
the costimulatory molecules during antigen presentation by dendritic cells. After 
activation, CD4+ T cells proliferate and differentiate into three main types of Th cells 
with distinct cytokine secretion profiles and unique functional characteristics. These cells 
are referred to as Th1, Th2 and Th17 cells. Th1 cells produce IFN-γ and TNF-β, Th2 
cells secrete IL-4, IL-5, IL-6 and IL-10, while Th17 cells produce IL-17. A number of 
factors are involved in determining the differentiation process, among which cytokines 
are the most influential factors. Specifically, IL-12 and IFN-γ are important for Th1 
differentiation; IL-4 is critical for Th2 differentiation, while IL-6, IL-21 and TGF-β are 
essential for Th17 differentiation. In addition to effector cells, naïve CD4+ T cells are 
able to differentiate into several subsets of Treg cells, including induced Tregs (iTregs) 
and Tr1. Natural occurring Treg (nTreg) cells are generated from the thymic CD4+ T cell 
precursors. Tr1 cells produce high levels of IL-10 and are generated in the presence of 
immunosuppressive factors such as IL-10 or vitamin D3 dexamethasone (208).   
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As presented previously, CD4+ T cells proliferate robustly in the absence of Jak3, which 
mediates signals for IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21. However, γc cytokines seem 
to be essential for the differentiation of these activated cells into all three subsets of Th 
cells as well as Treg cells. First, as shown above, in the absence of γc-dependent cytokine 
signals, naïve T cells cannot differentiate into Th1 cells due to a dramatic decrease in 
IFN-γ production. Second, Paul and colleagues show that STAT5-deficient T cells do not 
secrete IL-4 or differentiate into Th2 cells when cultured under Th2-skewing conditions 
(73). Third, we find that the Th17-skewing cytokine environment is incapable of driving 
the differentiation of Jak3-deficient naïve CD4+ T cells into Th17 cells and that the 
production of IL-17 is significantly diminished without Jak3-dependent cytokine signals 
(Figure 4.1). Fourth, our previous work reports that naturally occurring Treg cells fail to 
be generated in Jak3-deficient mice. However, peripheral CD4+ T cells in Jak3-deficient 
mice have several characteristics of Tr1 cells. For instance, Jak3-deficient CD4+ T cells 
produce high levels of IL-10 and modestly inhibit the proliferation of wild type naive 
CD4+ T cell in vitro (128). Whether these cells prevent autoimmune diseases and control 
T cell number in vivo needs to be further elucidated. Finally, it is interesting to see that 
there is substantially more IL-2 production in Jak3-deficient cells cultured under either 
non-skewing or Th1-skewing conditions (Figure 4.2), indicating that Jak3-deficient cells 
stay in Th0 stage rather than differentiate into effector cells. 
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Figure 4.1 Th17 differentiation is impaired in Jak3-deficient cells.  
CD4SP thymocytes were isolated from Jak3+/- and Jak3-/- OT-II Bcl-2 mice, stimulated 
with anti-CD3 (1 μg/ml) plus anti-CD28 (4 μg/ml) and cultured under Th17-skewing 
conditions (IL-6 20 ng/ml, TGF-β 2 ng/ml and anti-IFN-γ 10 μg/ml) for 4 days. Cells 
were restimulated with DMSO or PMA (5 ng/ml) plus ionomycin (375 ng/ml) for 5h. 
Dot-plots show intracellular staining for IFN-γ versus IL-17.  
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Figure 4.2 Jak3-deficient cells secrete more IL-2.  
CD4SP thymocytes from Jak3+/- and Jak3-/- OT-II Bcl-2 mice (a) or CD4+ splenocytes 
from Jak3+/- OT-II-transgenic mice cultured with vehicle alone or PS078507 (625nM) (b), 
were stimulated under non- or Th1-skewing conditions for 4 days. Cells were 
restimulated with DMSO (red line) or PMA plus ionomycin (blue line) for 5 hours. 
Histograms show IL-2 intracellular staining. 
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Figure 4.2 
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Taken together, these studies suggest that in contrast to wild type CD4+ T cells that 
differentiate into Th1, Th2 or Th17 cells after activation, T cells lacking Jak3-dependent 
cytokine signals either stay in the Th0 stage or differentiate into Tr1-like cells (Figure 
4.3). Our work extends our understanding of the role of γc cytokines in adaptive 
immunity. Our data suggest that γc cytokines differentially regulate the proliferation and 
differentiation of naïve CD4+ T cells, such that γc cytokines directly instruct naïve CD4+ 
T cells to develop effector function without influencing cell cycle progression. Our study 
provides novel evidence that γc cytokines are key for naïve CD4+ T cels differentiation 
into effector cells and that these cytokines are a crucial checkpoint for a productive cell 
response. Our data also indicate that γc cytokines control the generation of effector and 
regulatory T cells and regulate the fine balance between immune and autoimmune 
responses. 
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Figure 4.3 A model of CD4+ T cell proliferation and differentiation in the absence of 
Jak3-dependent cytokine signals.  
After antigen stimulation, naïve wild type CD4+ T cells proliferate and differentiate into 
three major functional classes of T helper (Th) cells (Th1, Th2 and Th17) and several 
subsets of Treg cells (iTreg and Tr1), under the influence of specific cytokine 
environments.  These subsets produce distinct cytokine profiles as indicated. Natural 
occurring Treg cells are generated from thymic T cell precusors. Although naïve Jak3-
deficient CD4+ T cells proliferate robustly to activation signals, they are not able to 
differentiate into Th1, Th2 or Th17 cells. Instead, Jak3-deficient cells either secrete a 
substantial amount of IL-2 and stay in the Th0 status or differentiate into Tr1-like cells. 
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Signaling pathways for Th1 differentiation 
The dogma concerning Th1 differentiation is that TCR ligation is a fundamental and 
initial step for Th1 differentiation (Figure 4.4). Signals from TCR engagement activate 
several transcription factors, including NFAT, which promote the basal level of IFN-γ 
production (55). Binding of IFN-γ to IFN-γR activates STAT1, which induces the 
expression of T-bet, the master transcription factor for Th1 differentiation (25). In 
addition to directly transactivating IFN-γ (27, 31), T-bet promotes IL-12Rβ2 chain 
expression to strengthen IL-12 signaling (23). Binding of IL-12 to IL-12R phosphorylates 
STAT4 to amplify Th1 responses. Our studies identified a novel pathway of Th1 
differentiation, in which the IL-2/Jak3/STAT5 pathway controls the chromatin 
remodeling of the Ifng gene to permit the binding of T-bet to the Ifng promoter and 
transactivate gene expression.  
 
After TCR ligation, two parallel pathways are critical for T-bet function and Th1 
differentiation. One is the IFN-γ/STAT1 pathway which regulates T-bet expression as 
mentioned above. The other is the IL-2/STAT5 pathway, which depends on the 
production of IL-2 and the expression of high affinity IL-2 receptor. The role of IL-
2/Jak3/STAT5 signaling is to further open the Ifng locus, which is initially opened by 
TCR engagement, and to allow T-bet to bind to the Ifng promoter to transactivate the Ifng 
gene. 
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Alternativly, T-bet induction may not solely depend on the IFN-γ/STAT1 pathway. This 
idea is supported by several pieces of evidence. First, in our studies, we found that IFN-
γR-/- T cells were still able to up-regulate T-bet and produce IFN-γ (data not shown). 
Second, kinetic studies showed that IFN-γR and STAT1 phosphorylation were down-
regualted in the early stages of Th1 differentiation. For instance, IFN-γR was absent at 6h, 
24h, 7d or 14d following Th1 culture (Figure 3.12, (204)) and STAT1 phosphorylation 
was also undetected at 3h or 24h after initial activation (Figure 3.12, (205)). This data 
indicate an althernative pathway to the induction of T-bet. The possible signals include 
TCR (209) and Notch signaling (210), which have been shown to induce T-bet 
expression. Nevertheless, the binding of T-bet to the Ifng promoter is controlled by the 
ability of IL-2/Jak3/STAT5 signaling to induce chromatin remodeling activity at the Ifng 
locus.  
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Figure 4.4 Signal pathways for IFN-γ transcription during Th1 differentiation. 
TCR ligation promotes the basal level of IFN-γ production, which activates STAT1 
through IFN-γR. Activated STAT1 induces T-bet expression. Alternatively, T-bet 
expression can be induced by TCR engagement or Notch signaling. In addition to directly 
transactivating IFN-γ, T-bet promotes IL-12Rβ2 chain expression to strengthen IL-12 
signaling, which amplifies Th1 responses. The role of IL-2/Jak3/STAT5 signaling is to 
further open the Ifng locus, which is initially opened by TCR engagement, and to allow 
T-bet to bind to the Ifng promoter to transactivate the Ifng gene. 
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Figure 4.4 
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Molecular mechanisms for Th differentiation 
Th subsets are classified by the distinct cytokine profiles which are the consequence of 
differential gene transcription. Gene transcription is regulated at multiple levels. One 
level of regulation is through controlling the abundance, modification and location of 
transcription factors. The other level is provided by epigenetic regulation of the 
accessibility of these transcription factors to their target elements. Thus, by modulating 
the probability with which transcription factors bind to the regulatory regions of genes, 
epigenetic regulation may act to set a threshold that transcription factors must exceed to 
promote gene expression.  
 
The molecular mechanisms by which Jak3-dependent cytokine signals control the 
differentiation of naïve CD4+ T cells is intriguing to explore. To date, several CNS sites 
have been found at the Ifng locus, located at 34kb, 22kb, 5kb  and 0.3kb upstream and 
18kb downstream of the transcription initiation site of the Ifng gene(90, 91, 95). These 
elements function as enhancers and are associated with Th1 cell specific expression of 
the Ifng gene. Among these, CNS-22 is unique due to its substantial histone modification, 
not only in Th1 cells but also in naive CD4+ T cells. In this regard, it can be proposed that 
CNS-22 is a chromatin entry point for transcription or remodeling factors to expose other 
chromatin sites throughout the Ifng locus (91, 98). CNS-22 contains binding sites for a 
number of transcription factors, such as T-box factor, STAT, GATA, IRF, NF-κB and 
Ikaros, although which transcription or remodeling factor functions as a chromatin 
remodeling initiation factor is not clear. Our data demonstrate that Jak3/STAT5 is 
  
157
involved in the epigenetic regulation of the Ifng locus and that STAT5 binds to the CNS-
5 region during Th1 differentiation. It is tempting to speculate about a sequential model 
where other transcription factors and STAT5 function cooperatively to control the 
transcription of the Ifng gene. As shown in figure 4.5a, chromatin remodeling initiation 
factors bind to the CNS-22 element and initiate the chromatin remodeling of the Ifng 
gene, leading to the opening of the CNS-5 area to STAT5. Here, STAT5 acts as a 
checkpoint for further opening of the Ifng gene locus. Under the optimal Th1-skewing 
conditions, STAT5 further changes the chromatin configuration with the help of T-bet, 
resulting in the accessibility of other regulatory elements to remodeling factors. 
Subsequently, the proximal promoter of the Ifng gene is open to transcription factors, 
including T-bet, leading to the activation of Ifng gene transcription. The data presented in 
this thesis refine the understanding of Th1 differentiation by showing that in addition to 
general regulation, there is fine regulation of epigenetics and I propose that Jak3/STAT5 
is a passport to fully open the Ifng gene locus. In addition to Th1 cells, CNS−22 appears 
to be essential for expression of the Ifng gene in CD8+ T and NK cells (91). STAT5 has 
been found to bind to the Ifng locus in NK cells (199). Thus, the sequential model I 
proposed for Th1 cells may be applied to CD8+ T and NK cells as well.  
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Figure 4.5 Model of the orderly chromatin changes in the Ifng and Il4 locus during 
the commitment of naïve T cells to the Th1 or Th2 lineage. 
(a) Chromatin of the Ifng gene in naïve CD4+ T cells is basically condensed except the 
CNS-22 region. Chromatin initiation factors bind to CNS-22, leading to the partial 
opening of the Ifng locus and the exposure of CNS-5 region. STAT5 then accesses CNS-
5 and fully opens the Ifng gene with the help of T-bet, which allows general and specific 
transcription factors to bind to the proximal promoter of the Ifng locus to activate Ifng 
gene transcription.  
(b) In naïve CD4+ T cells, chromatin structure along the Il4 gene is highly compacted. 
Following activation, GATA3 binds to the regulatory element CNS1 and VA, and 
mediates the partial remodeling of the Il4 gene, resulting in the accessibility of HSII and 
HSIII sites. Binding of STAT5 to HSII and HSIII completely opens the Il4 locus which 
allows for transcription factors to access the proximal promoter region and initiate Il4 
gene transcription. 
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Figure 4.5 
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Several regulatory elements have been identified in Th2 cells, which are DNase I 
hypersensitivity sites II and III (211), DNase I hypersensitivity sites 3′ of the Il4 gene 
(HSV) (81), activation-dependent hypersensitivity site (VA) (212)) and CNS1 (213) 
(Figure 4.5b). GATA3 has been shown to bind to CNS1 (214) (68) and VA (68, 212) to 
open the Il4 locus. Paul and colleagues demonstrate that STAT5, in contrast, binds to HS 
site II and III to remodel the Il4 chromatin and lack of GATA3 or STAT5 leads to the 
incomplete opening of the Il4 gene(73, 74). Furthermore, Paul’s group reports that the 
initiation of chromatin remodeling around the HSII and HSIII region of the Il4 locus is 
independent of IL-2/STAT5 signaling, whereas the maintenance of the accessibility of 
these regions needs IL-2/STAT5 signal (73). Based on these data, we speculate that 
GATA3 and STAT5 collaborate to regulate chromatin remodeling of the Il4 gene, such 
that GATA3 binds to CNS1 and VA to initiate chromatin remodeling of the Il4 locus. 
Binding of STAT5 to HSII and HSIII provides permission to fully open the Il4 gene 
locus. It is interesting to note that the mechanisms by which the lineage-specific and non-
specific factors cooperate to render the accessibility of a lineage-specific gene are very 
similar between Th1 and Th2 cell differentiation. 
 
Th17 cells are a newly discovered subset of Th cells that produce IL-17. It has been 
shown that STAT5-deficient cells produce more IL-17, suggesting that IL-2/STAT5 
signaling constrains the generation of Th17 cells (215). However, the data presented in 
this thesis show that Jak3-deficient cells are unable to secrete IL-17 under Th17-skewing 
conditions. The disagreement of the Th17 cell generation between STAT5- and Jak3-
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deficient cells could be explained as follows: STAT3 is an essential transcription factor 
for Th17 differentiation by directly promoting IL-17 production(216) or by inducing the 
expression of the Th17-specific transcription factor retinoic acid-related orphan receptor 
(RORγt) (21, 22). The activation of STAT3 may be reduced in Jak3-deficient cells 
because IL-21 is a γc cytokine that activates STAT3. This γc cytokine is crucial in 
amplifying Th17 differentiation and preferentially induces STAT3 and STAT1 activation 
through Jak3 and Jak1 (217). Therefore, cells lacking Jak3-dependent cytokine signals 
cannot differentiate into Th17 cells.  In contrast, STAT5 suppresses IL-17 production 
through its competitive inhibition of STAT3 (215). Without the inhibitory effect of 
STAT5 during Th17 differentiation, STAT3 induces STAT5-deficient cells to produce 
more IL-17. The precise manner in which STAT3 functions in the Th17 generation 
remains to be elucidated. One possibility is that STAT3 regulates the expression of the 
Il17a/f gene at the chromatin level since STAT3 directly binds to the Il17a/f gene (216), 
and the polarization of Th17 cells is presumably accompanied by selective chromatin 
remodeling events (218). Therefore, it is possible that like Th1 and Th2 differentiation, 
Jak3-dependent cytokine signals regulate Th17 differentiation through epigenetic 
modification. Future work needs to be done to clarify whether STAT3 activation and 
RORγt expression are impaired without Jak3-dependent cytokine signals and how γc 
cytokine signals regulate the epigenetics of Il17 locus. 
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IL-2 functions as a survival and differentiation factor for CD4+ T cells following 
initial activation 
Activation, proliferation and differentiation of T cells form the basis for the generation of 
immunocompetent cells, which allow the immune system to eliminate pathogens while 
protecting self structures. At the early stages of an immune response, also known as the 
expansion phase, activation of naïve T cells through the TCR and co-stimulatory 
molecules leads to the proliferation of antigen-specific T cells, which are needed to clear 
pathogens from the body. However, T cell proliferation is always accompanied by death 
to restrict the over-reaction of the immune responses. The outcome of T cell expansion 
depends on the net result of these two events. Each of these two processes may be under 
the control of multiple factors, such as TCR signaling, co-stimulatory triggering and 
signals from cytokines. Activation and proliferation of T cells result in their 
differentiation into distinct effector subsets depending on the cytokines present during the 
activation process.  
 
IL-2 is a cytokine produced mainly by activated T lymphocytes. Kinetic studies show that 
the expression of IL-2 and the high affinity IL-2R (CD25) are in a transient manner. For 
example, IL-2 protein is detected several hours after antigen stimulation, peaks at 48h, 
and dramatically decrease at 72h (219, 220). Similar to IL-2 production, activated T cells 
express CD25 on their surface on day 1 after DC priming in vivo  and down-regulate its 
expression to the level of naïve cells on day 3 (221, 222). Together, these data suggest 
that IL-2 functions in the early stages of immune responses.  
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As presented in chapter II, our data showed that T cell in vitro proliferation does not need 
signals from γc cytokines. Several studies have reported that γc cytokines are redundant 
for antigen-specific T cell proliferation in vivo (125, 130).  At this point, we think that IL-
2 may not directly affect the proliferation of T cells. TCR and co-stimulatory molecules 
provide strong signals to sufficiently drive cells into the cell cycle. However, our results 
suggest that the survival of activated T cell is greatly dependent on γc cytokines, which is 
supported by other studies (130). Using genechip analysis, we found that several anti-
apoptotic factors are substantially down-regulated in activated CD4+ T cells when IL-2 
signals are blocked (unpublished data from our lab), such as Bcl-2, Bcl-3 and Pim-1 
(Proviral integration of the moloney murine leukemia virus in mice). Furthermore, in vivo 
IL-2 therapy during the expansion phase enhances the magnitude of effector T cell 
responses (223, 224). These data indicate that IL-2 is critical for the survival of activated 
T cells after initial activation.  
 
As shown in this thesis, IL-2 is essential for Th1 differentiation. It has been found that 
IL-2 is critical for Th2 differentiation (74, 215)  and inhibits Th17 differentiation (215). 
Together, in addition to acting as a survival factor, IL-2 controls the CD4+ T cell fate 
decision with the help of other lineage specific cytokines during the early stages of the 
immune responses.  
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 Overall, upon encounter with antigen-carrying dendritic cells in the secondary lymphoid 
organs, naïve CD4+ T cells become activated and proliferate, which is driven by TCR and 
co-stimulatory signals. In the first 3 days, activated T cells produce IL-2 and express 
CD25 for IL-2 responsiveness. The importance of IL-2 during this period is to maintain 
the survival of activated T cells and induce CD4+ T cell differentiation. 
 
The significance of this work 
The work presented in this thesis attempts to understand the role of γc cytokine signals 
during T cell activation, proliferation, survival and differentiation. Studies of individual 
γc cytokines or γc cytokine receptors are important to establish the non-redundant roles of 
each cytokine. However, studies of Jak3, the master tyrosine kinase which transmits 
signals for all γc cytokines, have the unique capacity to discover additional and redundant 
functions of this family of cytokines.   
 
Severe combined immunodeficienty (SCID) is a group of inherited defects in the immune 
system that has been recognized for more than 50 years. SCID patients fail to develop T 
or NK cells due to defective cytokine signaling. Although B cells are present in these 
patients, their function is greatly impaired. The defects in immune cell development and 
function lead to significant deficits in host defense (225, 226). Due to the recurrent and 
opportunistic infections with a potentially lethal outcome, SCID necessitates prompt 
diagnosis and treatment. It is known that mutation of Jak3 gene is highly associated with 
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SCID (227, 228). Therefore, analysis of the animal model that lacks the function of Jak3 
provides great insights into the pathophysiology of these disorders and offers new 
avenues for diagnosis and therapy of SCID patients. 
 
Significant efforts are currently underway to develop pharmacological inhibitors of Jak3 
for use as an immunosuppressive drug to inhibit autoimmune diseases, inflammatory 
diseases or organ graft rejection (229-231). A more thorough understanding of how these 
autoreactive or alloreactive T cells are generated and how this process contributes to the 
generation of effector T cells during an immune response may benefit the development of 
new strategies to block disease processes. Furthermore, knowing that agents used in 
disease treatment may have a number of side effects, a better knowledge of their 
mechanism of action may lead to the design of new molecules to improve the specificity.  
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CHAPTER V 
Materials and Methods 
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Mice 
Jak3-/- mice (112) were backcrossed to C57BL/6 for ten generations. OTII-transgenic 
(195)and Bcl2-transgenic (196) mice were purchased from Jackson laboratory (Bar 
Harbor, ME). Jak3-/- OT-II Bcl2 were generated by crossing Jak3-/- mice to OT-II and 
Bcl2-transgenic mice to generate Jak3+/- and Jak3-/- OTII+ Bcl-2-transgenic mice. 
Stat5ab double-deficient mice (201) and CD2-cre transgenic mice (202) were generously 
provided by Dr. Joonsoo Kang with the permission of Dr. Lothar Hennighausen and Dr. 
Dmitris Kioussis, respectively. All mice and their littermate controls were sacrificed 
when they were 6-10 weeks of age. Mice were maintained at the University of 
Massachusetts Medical School specific pathogen-free animal facility after review and 
approval by the institutional animal care and use committee.  
 
Jak3 inhibitor 
PS078507 was developed at Pharmacopeia, Inc. (Princeton, NJ).  A stock solution (10 
mM) was prepared by dissolving PS078507 in dimethylsulfoxide (DMSO) (Sigma 
Chemical Co., St. Louis, MO).  All working compound solutions were made by serial 
dilution in buffer or culture medium.  DMSO was used as a vehicle control.  
 
Kinase assays 
Recombinant human Jak1 and Tyk2 were purchased from Carna Biosciences (Kobe, 
Japan).  Recombinant human Jak3 and Jak2 were expressed using the Bac-to-Bac 
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Baculovirus Expression Systems according to the manufacturer’s instructions 
(Invitrogen, Carlbad, CA).  Briefly, cDNA fragments of Jak3 (508aa to 1124aa) and Jak2 
(532aa to 1132aa) were amplified by PCR and cloned into the pFastBac vector with 
glutathione-S-transferase as a tag at the amino terminal to generate bacmid DNA.  The 
Sf9 insect cells were used to generate baculovirus stock and to express recombinant Jak3 
and Jak2. A homogeneous time-resolved fluorescence assay was used to assess kinase 
activity of Jak kinases using biotinylated poly Glu-Ala-Tyr as the protein substrate.  Jak 
kinases were incubated with the substrate and ATP in the presence or absence of 
PS078507 for 60 min at room temperature. The reaction was terminated by adding 
EDTA, and the tyrosine phosphorylation was detected using Europium (LANCE) labeled 
anti-phosphotyrosine antibody (Eu-PT66; PerkinElmer, Wellesley, MA) and DyLight 
conjugated streptavidin (PIERCE, Rockford, IL).  Time-resolved fluorescence signals 
were measured using a Victor2V plate reader (PerkinElmer) at 615 nm and 665 nm.   
 
Cell proliferation assay 
Aliquots of cryopreserved peripheral blood mononuclear cells (PBMC) were purchased 
from AllCells (Emeryville, CA).  PBMC were resuspended in complete RPMI 1640 
medium (RPMI 1640 medium supplemented with 10% fetal bovine serum, 
penicillin/streptomycin, 2 mM L-glutamine and 1 mM sodium pyruvate).  PBMC were 
cultured with the mitogenic lectin phytohemagluttinin (PHA) at a final concentration of 
10 μg/ml for 3 days to upregulate IL-2 receptor and JAK3.  PHA-activated PBMC were 
harvested, washed once with complete RPMI medium, resuspended in complete RPMI 
  
169
medium, and seeded in 96-well plates (90 μl/well, 10,000 cells/well) in the presence or 
absence of IL-2 (10 ng/ml final; R&D Systems, Minneapolis, MN).  Test compounds 
were serially diluted in DMSO followed by intermediate dilution in complete medium.  
Compounds (10 μl/well) were added to cells at a final DMSO concentration of 1%.  Cells 
were incubated for 48 h at 37°C, 5% CO2.  The number of viable cells was determined 
by the CellTiter-Glo Luminescent Cell Viability Assay kit (Promega, Madison, WI) 
according to the manufacturer’s instructions.  
 
Cell isolation, culture, and in vitro T cell differentiation 
Thymocytes were harvested from Jak3+/- and Jak3-/- OT-II Bcl2 mice, red blood cells 
were lysed, and cells were incubated with anti-CD4-PE (BD Pharmingen, San Diego, 
CA) and anti-CD8-APC (BD Pharmingen).  CD4 SP thymocytes were sorted by flow 
cytometry on a Mo-Flo sorter (Cytomation, Fort Collins, CO) to a purity of >98%.  
Splenocytes from Jak3+/+ OTII-transgenic mice were incubated with CD4 antibody-
coated magnetic microbeads, and CD4+ T cells were purified by positive selection 
(Miltenyi, Auburn, CA) to a purity of >94%.  T Cells were stimulated with plate-bound 
anti-CD3 (1 μg/ml) plus anti-CD28 (4 μg/ml) (eBioscience, San Diego, CA), unless the 
concentrations were specified. T cells were cultured in 24-well plates at 1.2 × 106 cells/ml 
in RPMI 1640 supplemented with 10% heat inactivated fetal calf serum, 2 mM 
glutamine, 100 iu/ml penicillin, 100 ug/ml streptomycin, 50 μg/ml geneticin, 2 uM β-
mercaptoethanol, and 25 mM HEPES. For Th1 differentiation, cells were stimulated with 
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rIL-12 (5ng/ml) (R&D, Minneapolis, MN) and anti-IL-4 (5μg/ml) (BD Pharmingen). For 
Th2 differentiation, cells were stimulated with rIL-4 (20ng/ml) (R&D) and anti-IFN-γ 
(5μg/ml) (BD Pharmingen).  For non-skewing conditions, no exogenous cytokines or 
antibodies were added.  For all culture conditions, no exogenous IL-2 was added.  
 
Analysis of cell proliferation by thymidine incorporation 
Isolated CD4+ CD44lo cells were plated out at a density of 1 × 105 cells /180 μl in 
triplicate in a 96-well flat-bottomed plate and stimulated with various concentrations of 
anti-CD3 and anti-CD28 or mitomycin C-treated C57BL/6 antigen presenting cells 
(APCs) plus the indicated concentrations of OVA323-339.  Forty-eight hours later, cells 
were pulsed with one microcurie of [3H]-thymidine for 18h, and harvested on a Tomtec 
Harvester 96 (Orange, CT). Thymidine incorporation was quantified on a Trilux 
microbeta counter (PerkinElmer, Wellesley, MA).  
 
Analysis of cell proliferation with carboxyfluorescein diacetate succinimidyl ester 
(CFSE) 
Isolated cells were washed once in PBS and resuspended at a density of 2.5 × 107 cells/ml 
in PBS. CFSE was added to a final concentration of 2.5 μM. The cell suspension was 
mixed thoroughly and placed at 37°C for 12 min and the reaction was terminated by 
adding RPMI 1640 with 10% fetal calf serum. The cells were then plated at 1.2 × 106 
cells/ml in 24-well plates coated with anti-CD3 (1 μg/ml) and anti-CD28 (4 μg/ml) 
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antibodies. Three days later, the fluorescence of the cells was determined by flow 
cytometry. 
 
Apoptotic analysis 
Stimulated T cells were harvested, washed with cold PBS and resuspended in 1× BD 
PharmingenTM Annexin V Binding Buffer to achieve a final concentration of 10.0 × 106 
cells/ml. 5 μl of Annexin V-FITC and 7-AAD were added to 100 μl solution (~1 × 106 
cells) and incubated at room temperature for 15 min in the dark. Apoptosis was analyzed 
by flow cytometry within 1h.  
 
Cell cycle analysis by flow cytometry 
One million naïve or activated T cells were washed with cold PBS and fixed overnight at 
-20°C in 95% ethanol. Cells were then pelleted, washed and resuspended in 1 ml PBS 
with the propidium iodide (PI) at a final concentration of 20 μg/ml, ribonuclease at 20 
μg/ml and EDTA at 2mM.  The cells were incubated at 37°C for 30 min in the dark. PI 
content were assessed by flow cytometry. 
 
Intracellular cytokine staining 
One million T cells cultured under non-skewing or Th1-skewing conditions were 
restimulated with phorbol myristate acetate (PMA) (5ng/ml) plus ionomycin (375ng/ml) 
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for 5h in a 96-well plate. Golgi Plug (MD Pharmingen) was added for the last 4h. The 
cells were first stained with cell surface marker, and then fixed, permeabilized, and 
stained with anti- IFN-γ-APC (BD Pharmingen) using intracellular staining 
Cytofix/Cytoperm kit protocol (BD Pharmingen), following the manufacture instructions. 
 
Cytokine ELISA 
Three hundred thousand T cells cultured under Th1- or Th2-polarizing conditions were 
restimulated with PMA (5ng/ml) plus ionomycin (375ng/ml) for 24h. Supernatants were 
harvested, serially diluted and assayed for IFN-γ, IL-4, IL-5 and IL-10 using cytokine 
detection kits (BD Pharmingen). 
 
Real-time quantitative PCR 
CD4 SP thymocytes from Jak3+/- and Jak3-/- OT-II Bcl2 mice were stimulated for 4 days 
with anti-CD3 and anti-CD28 under non-, Th1- or Th2-skewing conditions. Freshly 
isolated CD4 SP thymocytes were used as controls. Total RNA was extracted using 
TRIzol reagent (Invitrogen, Carlsbad, CA), according to the manufacturer’s protocol. 
Following DNAase treatment (Promega, Madison, WI), RNA was reversed transcribed 
into cDNA using Superscript II and Random Hexamers (Invitrogen), according to the 
manufacture instructions. Real-time quantitative PCR was performed on a Bio-Tad 
iCyclerTM by using SYBR® Green PCR Core Reagents (PE Applied Biosystems, Foster 
City, CA). 18srRNA were used as internal control. All PCR reactions comprised 40 
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cycles of denaturation at 95°C for 25-30s, 25-35s of primer annealing at 58°C, 58.5°C, 
62°C, 55°C, 56°C or 57.5°C for Ifng, T-bet, 18srRNA, IL-12Rβ2, Ets-1 and  Hlx 
respectively, and followed by a 25-30s extension step at 72°C. The following primers 
were used: Ifng sense, 5’-CCTGCAGAGCCAGATTATCTC-3’, anti-sense, 5’-
CCTTTTTCGCCTTGCTGTTGC-3’; T-bet sense, 5’-TTCCCATTCCTGTCCTTCACC-
3’, anti-sense, 5’-TGCCTTCTGCCTTTCCACAC-3’; 18srRNA sense, 5’-
TGGTGGAGGGATTTGTCTGG-3’, anti-sense, 5’-TCAATCTCGGGTGGCTGAAC-3’; 
IL-12Rβ2 sense, 5’-CCCAAGGAAATGAAAGGGAAT-3’, anti-sense, 5’-
TAGCGATGCAAATGCTTGATATC-3’; Ets-1 sense, 5’-
GCGCTACGTATACCGCTTTG-3’, anti-sense, 5'-CAACCAACAGGGTTGCTCTT-3'; 
Hlx sense, 5’-GGGACAGTTCTTCGCATCTC-3’, anti-sense, 5’-
CTGTGGCATGGTGTCCTTAG-3’. 
 
Immunoblot 
Naïve cells or activated cells were harvested at the indicated time points, washed and 
lysed in RIPA buffer for 20 min on ice. The protein fraction was separated by 
centrifugation at 13,000 rpm for 10 min at 4°C and protein level was quantified with the 
Bio-Rad protein assay (Bio-Rad, Hercules, CA). Proteins were separated on SDS-PAGE 
and transferred onto nitrocellulose membranes. The membranes were immunoblotted 
with antibodies to cyclin D2 (Santa Cruz Biotechnology, Santa Cruz, CA), cyclin E 
(Santa Cruz Biotechnology), cyclin A (Santa Cruz Biotechnology), p27kip1 (Santa Cruz 
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Biotechnology), PI-3-kinase p85 (Cell Signaling Technology, Danvers, MA), phospho-
Stat5 (Cell Signaling Technology) and β-actin (BD Pharmingen) antibodies. 
 
Freshly isolated cells (naïve) or Th1-polarizing cells (Th1) were harvested, lysates were 
prepared, proteins were separated by PAGE, and transferred to nylon membranes.  
Membranes were immunoblotted with antibodies to T-bet (Santa Cruz Biotechnology, 
Santa Cruz, CA), β-actin (BD Pharmingen), phospho-Stat1 (Tyr701) (Cell Signaling 
Technology, Danvers, MA), total Stat1 (Cell Signaling Technology), phospho-Stat4 
(Y693) (Invitrogen, Carlsbad,CA), total Stat4 (Santa Cruz Biotechnology) and phospho-
Stat5 (Cell Signaling Technology) antibodies. 
 
Chromatin immunoprecipitation 
ChIP assays were performed by using the ChIP Assay Kit (Upstate Cell signaling 
Solutions, Charlottesville, VA), according to manufacture’s instructions with minor 
modifications. Briefly, 1.5×106 cells were fixed by adding formaldehyde directly to 
culture medium to a final concentration of 1% and incubated at 37°C for 10 minutes. 
After incubation, glycine was added to a final concentration of 0.125M for 5 minutes. 
Cells were rinsed once with ice cold PBS containing protease inhibitors (1mM 
phenylmethylsulfonyl fluoride (PMSF), 1μg/ml aprotinin and 1μg/ml pepstatin A). Cells 
pellets were resuspended in 100μl of SDS Lysis Buffer containing protease inhibitors 
indicated as above and incubated for 10 minutes on ice.  The suspension was sonicated 
with ultrasonic processor (cole-parmer instrument, Vernon Hills, Illinois) for 6 times with 
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at least 1 minute cooling on ice in-between. The conditions for each time as follows: 
amplitude 40, timer 1min, and pulser 10sec. Cellular debris was removed by 
centrifugation for 10 minutes at 13,000g at 4°C. The supernatant was diluted 10 fold in 
ChIP Dilution Buffer with protease inhibitor as above.  An aliquot of diluted supernatant 
was used as input DNA control after reverse cross-linking. The diluted cell supernatant 
was pre-cleared with agitation with Protein A Agarose/ Salmon Sperm DNA for 1 hour at 
4°C. Agarose was discarded by briefly centrifugation. Immunoprecipitation overnight at 
4°C on a rotor was performed by using anti-T-bet (H-210, Santa Cruz), anti-acetylated 
histone H3 (Upstate), and anti-Stat5a (R&D), with anti-IgG (Santa Cruz) as a negative 
control. Immunocomplexes were precipitated with Protein A Agarose/ Salmon Sperm 
DNA on a rotor for 1 hour at 4°C,  washed 5 times with  provided Wash Buffers and 
eluted with freshly prepared elution buffer (1%SDS, 0.1M NaHCO3). Following reverse 
cross-linking and protein digestion, the DNA was recovered by phenol-chloroform 
extraction, precipitated with the help of 20 μg of glycogen and resuspended in 50 μl of 
TE buffer.  
 
PCR was performed with 5μl from a total of 50μl of the immunoprecipitated DNA with 
various primers. As a control, the PCR was done directly on input DNA purified from 
chromatin before immunoprecipitation. PCR products were resolved on 2.5% agarose 
gels or 6% polyacrylamide gels and visualized with ethidium bromide staining or silver 
staining, respectively. For T-bet ChIP assay, PCR comprised 40 cycles (of denaturation at 
95°C for 30s, primer annealing at 56°C for 30s and lastly a 30s extension step at 72°C. 
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For Histone H3 ChIP assay, PCRs included 30 cycles of denaturation at 95°C for 30s, 30s 
of primer annealing at 60°C or 55°C for primer set #3 and #4 respectively, followed by 
an extension step at 72°C for 30s. For Stat5a ChIP assay, PCRs were performed for 40 
cycles of denaturation at 95°C for 30s, 30s of primer annealing at 56°C and 30s of 
extension at 72°C. Positions of primers are indicated on a map of the murine Ifng locus 
(Figure 2.6). Primers to detect T-bet binding (Lovett-Racke et al., 2004) were set #1 
(Figure2.6): 5’-CACGTTGACCCTGAGTGAT-3’ and 5’- GAGGAAACTCTTGGGCTT 
C-3’; primers for Stat5a binding were set #6 for IfngCNS-34: 5’-
AAGCCCAGAGTGTCAACCAC-3’ and 5’-GGATCATCTAGCAGCCGTTG-3’, set #7 
for IfngCNS-22: 5’-CACAGGAAGGAGATGGGAAG-3’ and 5’-
CCCGTTAACCTTCTGCTCTG-3’, set # 8 for IfngCNS-5.5: 5’-
CCGTGTGGACTTCCATTCTC-3’ and 5’-GTTACCTCCTCCACCCGTTC-3’, set #9 
for HS-3.6: 5’-ATCAGGAAGGAACAGGCTTC-3’ and 5’-
CCATCCTTTCGTCTCAGCTC-3’, set #5 for HS-0.3: 5’-
TGCTGTGCTCTGTGGATGAG-3’ and 5’-GGGCTCTCTGACGATGAGAC-3’, and set 
#10 for Ifng CNS+18: 5’-AAGCCAGTTTGTCATCATGC-3’ and 5’-
TTTGTGCTTTCCTGATTCACC-3’; primers to examine Histone H3 acetylation were 
set #3, 5'-CGTAATCCCGAGGAGCCTC-3' and 5'-CTTTCAATGACTGTGCCGTGG-
3', and set #4, 5'-GCTCTGTGGATGAGAAAT-3' and 5'-AAGATGGTGACAGAAGG-
3'. 
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Restriction enzyme accessibility assay 
Restriction enzyme accessibility experiments using LM-PCR were performed as 
previously described (de la Serna et al., 2005) with some modifications. CD4SP 
thymocytes from Jak3+/- and Jak3-/- OT-II Bcl2 mice were stimulated under Th1-skewing 
conditions for 4 days. Freshly-isolated cells (naïve) were used as controls. 6×106 Cells 
from each group were washed with cold PBS, resuspended in 1ml of freshly prepared 
lysis buffer (25mM Hepes at pH7.9, 15mM MgCl2, 10mM KCl, 0.1% NP40, 1mM DTT, 
1mM phenylmethylsulfonyl fluoride PMSF, 1μg/ml aprotinin and 1μg/ml pepstatin A) 
and incubated on ice for 10 minutes. Cells were homogenized by 20 strokes with Dounce 
B Homogenizer. Nuclei were spanned down at 1,000g for 4 minutes, washed once with 
lysis buffer and resuspended in 100 μl of digestion buffer (300mM sucrose, 1× restriction 
enzyme digestion buffer and 100 μg/ml BSA). 14 μg nuclei were digested with 14U or 
28U HinfI at room temperature for 90 minutes with periodic agitation. The digestion was 
stopped by adding an equal volume of stop buffer (20mM Tris at pH 7.4, 20mM EDTA, 
0.4% SDS, 300mM NaCl and 1mg/ml proteinase K) and incubating overnight at 50°C. 
Genomic DNA was purified by Phenol-Chloroform extraction, precipitated by ethanol, 
resuspended in TE and the DNA concentration was determined by 260nm absorbance.  
HinfI LM-PCR adaptors were generated by annealing the two oligos (5’-
AATGAATTCAGATC-3’ and 5’-GCGGTGACCCGGGAGATCTGAATTC-3’) at 95°C 
for 5 min followed by cooling to 25°C. Adaptor ligation was performed by using DNA 
Ligation Kit Ver.2.2 (TaKaRa), according to manufacturer’s instruction. Basically, 1 μg 
of genomic DNA was mixed with 1 μl of 100μM adaptor, water was then added to bring 
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the volume to 5 μl. After adding 5 μl of Solution II (DNA Ligatin Kit Ver.2.2, TaKaRa) 
and 10 μl of Solution I (DNA Ligatin Kit Ver.2.2 TaKaRa), the ligation reaction was 
incubated overnight at 16°C. T4 DNA ligase was inactivated by heating the reaction at 
70°C for 10 minutes. LM-PCR comprised 35 cycles (30s at 95°C, 30s at 60°C and 30s at 
72°C). PCR for input control included 35 cycles (30s at 95°C, 30s at 56°C and 30s at 
72°C). The primers for LM-PCR (Figure 2.6, primer set #2) were as follows: 5’-
GGATATTACCACCAAAACTACGCAG-3’ (on Ifng promoter) and 5’-
GGTGACCCGGGAGATCTGAATTCATTCG-3’ (on LM-PCR adaptor). Input DNA 
was monitored by amplifying the Ifng promoter in a region that cannot be digested by 
HinfI using the following primers: 5’-GTTGACCGTGGTTGATGTTG-3’, and 5’-
TTGTACCTTGGACCTATACTATGC-3’. 
 
Statistical Analysis 
Statistical analysis was performed using the two-tailed paired student’s t test.   
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